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CHAPTER 1
INTRODUCTION
A positive blood alcohol concentration is detected in nearly half of burn
patients admitted to the emergency room. The combined insult of being intoxicated at the
time of burn injury results in more clinical complications, in comparison to nonintoxicated burn patients. Severe burn, with or without inhalation injury, is a common
predisposing factor for the development of acute respiratory distress syndrome (ARDS).
Exacerbated pulmonary inflammation and a net result of insufficient gas exchange
underlie the large percentage of burn fatalities due to pulmonary complications.
Previous studies in our laboratory indicate a drastic elevation in pulmonary inflammation
in a mouse model of intoxication and burn injury. This was characterized by heightened
levels of alveolar wall thickening, neutrophil accumulation, neutrophil chemokines KC
and macrophage inflammatory protein 2 (MIP-2), and pro-inflammatory IL-6. Reducing
levels of pulmonary inflammation and restoring the lungs to homeostasis is essential to
prevent lung complications and failure.
Alveolar macrophages (AMs) are the lungs first line of defense against inhaled
particles or pathogens and elegantly coordinate the on-set and resolution of inflammation.
The transition from steady-state healthy conditions to a pro-inflammatory state is a result
of macrophage plasticity to readily activate into a reversible pro- or anti-inflammatory
profile, depending on mediators present within the microenvironment. Importantly, AM
1
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efferocytosis of apoptotic cells stimulates anti-inflammatory mediator release and
promotes the resolution of inflammatory responses, while a disruption in this function
can result in drastically increased levels of inflammation.
A common feature of both ARDS and burn injury is an increase in apoptosis in
lung tissue. Specifically, ARDS has been associated with the apoptosis of lung epithelial
cells. Since the removal of apoptotic cells by AMs is important for the termination of
inflammation, a dysregulation in the activation state or survival of AMs can result in
prolonged pulmonary inflammation. Thus, the role of AMs in pulmonary inflammation
after intoxication and injury is extremely important. With this knowledge, we
hypothesize that intoxication at the time of burn injury leads to an increase in AM
apoptosis, resulting in exacerbated pulmonary inflammation and impaired lung function.
To test this hypothesis, three aims are proposed: 1) to determine if pulmonary
inflammation after intoxication and burn injury affects physiological parameters of lung
function, 2) identify the role of alveolar macrophages in post-burn pulmonary
inflammation, and 3) to determine if exogenous mesenchymal stem cell treatment will
attenuate pulmonary inflammation after intoxication and burn injury.
Lung function will be measured using non-restrained whole body
plethysmography. AMs will be isolated and their activation profiles will be assessed
using flow cytometry, immunofluorescent staining, and cytokine assays. Multiple
apoptosis identification methods, including TUNEL, Annexin V/PI, and caspase-3/7
staining, will be used to evaluate apoptosis in lung tissue and alveolar macrophages. The
role of alveolar macrophages in pulmonary inflammation after intoxication and injury
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will be determined by selectively depleting alveolar macrophages from the lungs with
clodronate liposomes. Finally, the ability of mesenchymal stem cells to attenuate
pulmonary inflammation will be assessed.

CHAPTER 2
REVIEW OF RELATED LITERATURE
Alveolar macrophages: key regulators of pulmonary inflammation
Lung anatomy
The respiratory system is an essential organ system that influences whole body
homeostasis; the import of oxygen and export of carbon dioxide is crucial to maintaining
the function of other vital organs. The respiratory system is comprised of the upper
respiratory tract (mouth, nose, pharynx, and larynx) and the lower respiratory tract
(trachea and within the lungs, the bronchi, bronchioles and alveoli). The lungs are
specifically essential to transporting oxygen to the capillaries and rest of the body. This
major organ system is organized into 2 lungs that are divided into a total of 5 lobes, a
likely evolutionary advantage in the event one lung or lobe is damaged. In humans, the
right lung is divided into 3 lobes while the left lung is divided into 2 lobes. In mice,
however, the lungs have a different anatomical makeup where the right lung is comprised
of 4 lobes and the left lung is smaller and comprised of a single lobe [1]. Other
anatomical differences in mice include the close positioning of the epiglottis to the soft
plate, which restricts breathing solely to the nasal passageways and makes oral breathing
nearly impossible.
The lung is intricately organized into a vast tree-like structure subdivided into
large and small airways. The larger airways include the trachea, bronchi and bronchioles,
while the smaller airways include the terminal bronchioles, alveoli ducts and the alveoli.

4
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As air is breathed in through the nose or mouth it passes through the trachea into the
bronchi and bronchioles until it reaches the alveoli, the minuscule bulb-shaped ends of
the airways that are the main functional components of gas exchange. Ninety-five percent
of the alveolar surface area is covered by large, flat type I epithelial cells, with an
occasional type II, surfactant-producing epithelial cell. Other cells found within the
alveolar wall include interstitial cells, as well as endothelial cells that comprise the
capillaries that are distributed throughout the walls [1]. The fusion of basement
membranes between the thin, type I epithelial cells and capillary endothelial cells creates
the alveolar septum where gas exchange occurs.
Alveolar macrophages (AMs)
In humans, the average size of an alveolus is about 0.25mm in diameter, while in
mice this is much smaller but exact measurements have not been determined. There is an
estimated 300 million alveoli within human adult lungs, calculating to an overall surface
area over 90 m2 [2, 3], while in mice, there is an estimated 2.3 million alveoli, resulting in
an area of 82.2 cm2 [4]. With its large surface area and direct connection to the outside
air, the lungs are continuously exposed to inhaled pathogens and particles and are at risk
for infection. Innate immune cells, alveolar macrophages (AMs), are strategically located
with in the alveolar space and are the most abundant antigen presenting cell in the lung
[5]. AMs monitor the airways for infectious agents, preventing excessive lung
inflammation, as well as stop pathogens from crossing the alveolar-capillary interface
into the bloodstream [6]. Under healthy conditions, AMs are 90-95% of airway cells (the
remaining fraction belonging to lymphocytes) [7-9], and in mice, it is estimated there are
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a total of 1-2 million AMs distributed within the airspace in the ratio of 1 AM to 3
alveoli [10]. During fetal development, AMs originate from monocytes [11], but adult
AMs are thought to be long-lived cells with a half-life of 30 days and minimal selfrenewal in naïve mice [12]. Other studies suggest lung-injury induced loss of AMs
stimulates local proliferation of AMs and is the main mechanism of repopulation [13-15].
It is also estimated that in steady-state conditions only 40% of AMs are replaced by
infiltrating monocytes within 1 year [16]. These long-lived AMs may comprise only 10%
of the total cells found in the alveoli, yet their function in maintaining a pathogen-free
environment is critical for lung homeostasis.
Lung environment determines AM phenotype
Macrophages were first described in 1892 by Russian scientist Ilya Metchnikoff
[17], but the isolation of AMs using bronchoalveolar lavage (BAL) was not described
until 1961 [18]. The alveoli are home to both AMs and interstitial macrophages (IMs),
but the ease of isolating a pure population of AMs through BAL has directed lung
immune research toward AM-focused studies [7]. Of note, there is also a population of
macrophages found in large airways, but at this time it is not known if this population
differs from AMs. Additionally, it is unclear whether the various methods of AM
isolation also include interstitial macrophages [19]. For the purpose of these studies, our
results indicate we have isolated a population of only AMs.
In mice, it has been shown AMs have a unique phenotype in comparison to IMs,
as well as other tissue-resident macrophages. Unlike macrophage populations found in
other organs, AMs express low to negative levels of classic macrophage marker CD11b,
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high levels classic dendritic cell (DC) marker CD11c, and eosinophil marker sialic
acid-binding immunoglobulin-like lectin F (Siglec-F), as well as low to negative
expression of major histocompatibility complex class II (MHC II) and high expression of
mannose receptor CD206 (Table 1) [20-22]. AM steady-state phenotype can be
classified as CD11c+CD11b-Siglec-F+F4/80+CD206+. Guth et al. demonstrated that the
lung environment rich in granulocyte/macrophage colony-stimulating factor (GM-CSF),
and to a lesser extent, surfactant protein (SP)-D, both produced by alveolar
epithelial cells, facilitates the uniqueness of the AM, specifically the expression of
CD11c [11, 20]. It is important to note that due to this environment, CD11c has also
been described on IMs, but in contrast to AMs, IMs are CD11b+Siglec-F-CD206low/(Table 1) [21]. Guth et al. also demonstrated that AMs cultured with medium for 24-48 h
before activation were able to present antigen in vitro and speculated that freshly isolated
AMs are not able to present antigen, presumably because of the immunosuppressive
properties of lingering surfactant proteins [23]. Both SP-A and SP-D have also been
shown to bind AMs through signal-regulatory protein α (SIRPα) and suppress AM
phagocytosis. Therefore, in addition to their ability to suppress antigen presentation, it is
likely these proteins have a significant role in suppressing AM pro-inflammatory
activation, overall preventing excessive inflammation in the lungs [24, 25].
Interestingly, Guth et al. also speculates this unique phenotype parallels that of an
immature DC cell. Development of macrophages is typically facilitated by CSF-1 and
DCs by GM-CSF [26], and, similar to immature DCs, but unlike other macrophage
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Table 1: Comparison of tissue-resident macrophage cell surface markers

Red font indicates unique phenotype markers on both AMs and IMs in the lung, in
comparison to other tissue-specific macrophage populations.

9
populations, AMs are constantly cleaning up the lung environment through
macropinocytosis [27]. Other research shows that SP-D binds to immature DCs, but not
mature DCs, further supporting why this phenotype may be advantageous to managing
lung inflammation [28]. This combination of a macrophage-dendritic cell phenotype that
is generated by the lung environment is advantageous for both steady-state and
inflammatory conditions. The ability of AMs to recognize and respond to non-infectious
agents and debris without initiating inflammation, but also have the ability to mount a
pro-inflammatory response to infectious agents, is an efficient function that keeps
inflammation under control.
Inhibitory receptors
In addition to surfactant protein binding to SIRPα, inhibitory receptors, such as
mannose receptor CD206, macrophage receptor with collagenous structure (MARCO),
and interleukin (IL)-10 receptor (IL-10R) on AMs are important in regulating
inflammation. CD206 on AMs is acquired during lung development [29] and selectively
binds bacterial glycoproteins and glycolipids. The interaction of CD206 with
unopsonized (not targeted for destruction) bacteria suppresses an inflammatory response,
highlighting a role for this receptor in maintaining tolerance against small amounts of
infectious agents or commensal bacteria located in the distal airways [30, 31]. In
humans, scavenger receptor, MARCO, is also important in binding unopsonized inhaled
particles and bacteria in the lung and aids in the clearance of apoptotic cells [32].
Moreover, ligation of IL-10R inhibits pro-inflammatory cytokine release and has been
shown to indirectly inhibit the toll-like receptor (TLR)-4 signaling pathway [33]. Recent
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studies by Westphalen et al. also demonstrated the interaction of AMs with the alveolar
epithelium and the use connexin 43 gap junctions allow AMs to communicate between
alveoli and suppress lipopolysaccharide (LPS)-induced inflammation [10]. Together,
these factors manage tolerance in the steady-state lung.
Activation profiles of AMs
Preventing excessive inflammation in the lungs is a tightly controlled process and
is facilitated by many different factors. The transition from the steady-state to a
necessary inflammatory state is made possible by the plasticity of macrophages to readily
activate into a reversible inflammatory profile, depending on factors present within the
microenvironment. Classification of macrophage activation profiles has varied since the
early 1990’s. It was not until recently that the major macrophage research investigators
collaborated and addressed the confounding classification terminology [34]. This group
of investigators determined 3 guidelines to use when describing the activation state of
macrophages. First, identify the model (in vitro versus in vivo) and method of isolation.
Second, identify the mediators that were used to stimulate macrophage activation. Lastly,
describe the upregulation or downregulation of cell surface or intracellular markers that
are associated with specific-mediator induced activation.
Prior to these guidelines, our laboratory generalized macrophages into either a
classical, pro-inflammatory M1 activated macrophage or an alternative, antiinflammatory M2 activated macrophage (this included all postulated subsets of M2: M2a,
M2b and M2c). Figure 1 outlines our generalized classification of M1 and M2
macrophages. M1 macrophages were characterized by mediators of activation, such as
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interferon gamma (IFNγ), tumor necrosis factor α (TNFα), and lipopolysaccharide
(LPS) that activate signal transducer and activator of transcription (STAT) 1 signaling
and upregulate MARCO, inducible nitric oxide (iNOS, Nos2), IL-6 and TNFα gene
expression. In contrast, M2 macrophages were summarized as activated by IL-4, IL-10,
IL-13 and transforming growth factor β (TGFβ) stimulating the STAT3 or STAT6
signaling cascade, and upregulating gene expression of CD206, IL-4R, IL-10, TGFβ,
arginase 1 (ARG1), resistin-like α (Retnla, Fizz1), and chitinase 3-like 3 (Chi3l3, Ym1)
[35]. Thus, the studies herein used these markers for the general classification of AMs in
our model (Figure 1).
Initiation and resolution of inflammation
AMs produce various pro-inflammatory cytokines in response to inflammatory
stimuli, including IL-6, TNFα, IL-1β, nitric oxide (NO), reactive oxygen species (ROS),
and neutrophil chemokine MIP- 2 [36-39]. AM release of IL-1β also stimulates epithelial
cells to produce large amounts of neutrophil chemokine CXCL8 (homologous to mouse
KC) that recruits neutrophils into the lung to aid in bacterial clearance [40]. Prolonged
pro-inflammatory activation of macrophages has been shown to result in tissue damage if
not regulated [41]. Therefore, lung inflammation needs to be a highly monitored process.
Resolution of inflammation is achieved through the removal of pathogens by
neutrophils and AMs, as well as the downregulation of neutrophil chemokines and the
removal of apoptotic neutrophils, both functions AMs [42]. Specifically, phagocytosis of
apoptotic cells (termed efferocytosis), such as neutrophils, by macrophages can
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Tissue Resident Macrophage Polarization

Senescent Macrophage
F4/80
IL-4
IL-10
IL-13
TGFβ

IFNγ
TNFα
LPS

F4/80

F4/80
ARG1
FIZZ
YM1

iNOS

MARCO

CD206
IL-4R

IL-6
TNFα

M1
Pro-inflammatory
Macrophage

IL-10
TGFβ

M2
Anti-inflammatory
Macrophage

Figure 1 : Macrophage activation profiles. Tissue resident macrophages express pan
macrophage cell surface marker F4/80 and retain this marker during their reversible
activation states. M1 macrophages can be polarized by pro-inflammatory mediators, such
as IFNγ, TNFα and LPS, subsequently releasing pro-inflammatory cytokines, such as IL6 and TNFα. M1 macrophages also upregulate intracellular iNOS gene expression and
can be characterized by upregulated levels of MACRO. M2 macrophages are polarized
by anti-inflammatory mediators IL-4, IL-10, IL-13, and TGFβ to secrete antiinflammatory cytokines, such as IL-10 and TGFβ. M2 macrophages can also upregulate
intracellular ARG1, Fizz, and YM1 gene expression, as well as cell surface markers
CD206 and IL-4R.
Modified from Clària et al., Front. In Immuno 2011
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downregulate TNFα, NO release and upregulate IL-10 and TGFβ [43-46]. Efferocytosis
by macrophages also helps facilitate restoration of lung tissue integrity through
macrophage release of epithelial growth factors platelet derived growth factor (PDGF),
vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) [47, 48]
and through their release of prostaglandin E(2), which stimulates endothelial cell
migration and promotes neoangiogenesis [49]. Additionally, migration of AMs to the
lung draining lymph nodes or the apoptosis of AMs themselves can promote the
resolution of inflammation [50, 51]. Overall, AM efferocytosis and apoptosis are both
important in the restoration and remodeling of injured lung tissue, but they are not
without consequence. Other studies have also shown that the increase in antiinflammatory mediators and a decrease in the number of neutrophils infiltrating into the
tissue, as a result of efferocytosis by AMs, can lead to an increased risk of secondary
infection if the lungs are not able to mount a pro-inflammatory response [52]. Taken
together, the initiation and resolution of inflammation is a closely synchronized process
that is dependent on AMs and their elegant role in coordinating both pro- and antiinflammatory responses.

Binge alcohol consumption paradigm
Alcohol drinking patterns
Historically, alcohol has been a common factor in various cultures for thousands
of years [53, 54]. Fermented beverages have been found as far back 6000 and 7000 BC in
Iran and China, respectively, and 3000 BC in Egypt [55-57]. The advancement of
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technology has led to the increased production, variety and wide distribution of alcohol,
ultimately resulting in the evolution of modern-day drinking patterns [58]. Only 7.4%
alcohol users are considered alcohol-dependent, revealing that the majority of alcohol
intake in the United States is through non-dependent patterns of occasional, moderate or
binge drinking [59]. Moderate drinking is defined as 2 drinks a day for men and 1 drink a
day for women and has been postulated to have positive health benefits, including
decreased risk of heart disease, stroke, and diabetes [60]. Interestingly, the consumption
of alcohol in a binge-like pattern is the most common form of drinking among young
adults, with half the alcohol consumed by adults being in the form of binge drinks and
69% of binge drinkers falling into a category of adults 26 years and older [61]. The
National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines binge drinking
either as either a blood alcohol concentration (BAC) level greater than or equal to 0.08%
(80 mg/dL) or by the number of drinks consumed within a 2 hour window, 5 drinks for
men and 4 drinks for women [62]. One drink is defined by the type of alcohol and
percentage of alcohol content within each beverage and is equivalent to either 12 oz.
of.beer (5% alcohol), 8 oz. of malt liquor (7% alcohol) 5 oz. of wine (12% alcohol) or 1.5
oz of 80-proof liquor (40% alcohol).
Binge drinking can be correlated with adverse health outcomes, especially
unintentional injuries, such as vehicle accidents, falls, and burn injury, making alcohol
the 3rd leading cause of preventable death [63]. Annually, there are about 88,000 alcohol
related deaths in the United States, two-thirds of which are men [64], while globally, in
2012, alcohol-related deaths reached 3.3 million a year, representing 6% of all global
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fatalities [65]. With over 50% of trauma patients presenting a positive BAC at the time
of hospital admission [66], it is important we understand how alcohol can modulate the
post-injury cellular and systemic response.
Alcohol mediates cellular responses
The immunosuppressive effects of alcohol consumption have been well
documented to correlate with increased incidences of infection [67]. Regardless of the
type of alcohol ingested, in mouse studies, a single exposure of alcohol (acute) alcohol
consumption can result in the suppression of cellular immune responses [68, 69]. The
function of various adaptive and innate immune cells, including T cells, DCs, monocytes,
and macrophages, are affected by alcohol exposure [67]. Ethanol is a small compound
with a hydrophobic carbon tail that allows itself to easily pass through phospholipid
bilayers in cell membranes [70]. It can modify lipid membrane properties and well as
directly interact with transmembrane proteins [71]. Specifically, acute alcohol has been
shown to increase membrane fluidity and decreased TLR4 migration to the cell surface,
overall downregulating TLR4-CD14 signaling pathways after LPS stimulation, and
highlighting a mechanism behind increased susceptibility to infection [72].
Human DC and monocyte studies have demonstrated acute alcohol can inhibit DC
and monocyte antigen presentation, as well as T cell proliferation [73, 74]. In murine
macrophages, acute alcohol exposure in vitro reduces TLR4 signaling and IL-6
production via the suppression of extracellular-regulated kinase 1 and 2 (ERK1/2) and
p38 mitogen-activated protein kinase (MAPK) [75]. Additionally, our laboratory has
shown that in vivo ethanol exposure suppresses both the production of IL-6, TNFα, and
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IL-12 after in vitro LPS stimulation of alveolar macrophages, as well as suppresses the
in vitro phagocytosis of Pseudomonas aeruginosa (P. aeruginosa) [8, 76]. Overall, these
data emphasize the profound affects a single exposure to alcohol can have on the immune
system.
Alcohol and the lung
Chronic alcohol consumption leads to an increased risk lung infections and a
decreased ability to clear the infection [77]. Acute ethanol exposure has also been
described to inhibit inflammatory responses in the lung in response to bacterial infection
[67]. The literature suggests that one mechanism behind increased incidences of infection
is the immunosuppression of alveolar macrophage function. Murine studies of chronic
alcohol exposure and infection showed a decrease in alveolar macrophage phagocytosis,
while rat studies with acute alcohol exposure revealed a decrease in the production of
TNFα [78, 79]. Additionally, alcohol abuse has been linked to an increase incidence of
acute respiratory distress syndrome (ARDS) [80]. ARDS is characterized by an increase
in tissue edema and permeability to inflammatory cells that can lead to impaired gas
exchange. In a murine model of LPS-induced lung injury, acute alcohol exposure in vivo
increased neutrophil recruitment in to the alveolar space and decreased AM efferocytosis
of apoptotic cells [81]. It has been postulated that resolution of inflammation in ARDS
patients is in part impaired due to the effects of alcohol on AMs, once again emphasizing
the importance of AMs in restoring normal lung function.
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Burn injury, alcohol and systemic inflammation
Incidences of burn injury in the Unites States
In the United States, there are over 480,000 incidences of burn injures that
require medical treatment [82]. The 2014 National Burn Repository Report revealed that
within these incidences of burn injury, 40,000 patients are admitted to the hospital and
over 3,200 patients per year succumb to either burn injury alone or burn injury and smoke
inhalation injury. Additionally, fire/flame injuries and scald injuries are the two most
frequent occurrences of injury, at 43% and 34% [82], respectively. Majority of patients
had an average burn size under 10% total body surface area (TBSA) and 70% of burn
patients are adult men. The cost of care for burn injury survivors is about $14,000 for
every day spent in the hospital, with an average total bill of $86,000 [82].
Interestingly, pneumonia is the most common complication associated with burn
injury and incidences of acquiring an infection correlated with an increased number of
days spent in the hospital. Severe burn, with or without inhalation injury, is a common
predisposing factor for the development ARDS [83, 84]. Clinical data show 42% of the
mortality observed in burn patients is due to pulmonary complications [85, 86].
Respiratory dysfunction in burn patients can be characterized by shallow breathing and
fluid accumulation in the lung interstitium, leading to heightened vascular resistance and
an increased effort to breathe [84, 86]. A net result of insufficient gas exchange underlies
the large percentage of burn fatalities due to pulmonary complications. Take together,
these observations emphasize the importance of extreme care given to the lungs after
burn injury.
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Intoxication and burn injury
Of the burn patients hospitalized each year, it speculated that nearly half of this
population is under the influence of alcohol [87, 88]. Burn patients are already
immunosuppressed and susceptible to systemic complications, but the addition of alcohol
at the time of injury increases the chance of morbidity and mortality. Silver et al.
estimated that patients that present to the emergency room with a positive BAC spend
twice as many days in the intensive care unit, three times as many days on a ventilator,
require more fluid resuscitation and 60% more surgical procedures than burn patients that
were not intoxicated at the time of injury [89]. A longer hospital stay and more days
intubated on a ventilator leads to an increased risk of pulmonary complications that
predisposes burn patients to multiple organ failure, with the lungs preceding all other
organs, as well as a higher chance of mortality [90, 91]. Additionally, research at our
institution showed that intoxicated burn patients with inhalation injury had a smaller
percent burn area in comparison to non-intoxicated burn patients. Yet, these patients still
required the same amount of burn care treatment as patients that were not intoxicated and
had larger injuries, acquiring a hospital bill of over $200,000 even with a mild injury
[92]. Thus, the combined insult of being intoxicated at the time of burn injury is worse
than burn injury alone.
Gut-Liver-Lung Axis
Pulmonary complications are proposed to arise as a result of damage in other
organ systems after burn injury. Multiple organ failure after burn injury is associated with
overgrowth of gut-derived bacteria and its translocation out of the intestinal lumen and
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into lymphatic and portal blood systems [93, 94]. In both mice and humans, the
gastrointestinal system is the first system to interact with alcohol after it is consumed and
it is the primary site of alcohol absorption. In animal models, the absorption of alcohol
by the gut prior to burn injury has been shown to increase intestinal permeability and the
translocation of bacteria and LPS out of the gut, in comparison to burn injury alone [9598]. With the majority of the portal blood supply filtering through the liver, increased
bacterial burden may result in a greater hepatic response [99, 100]. This, in turn, triggers
the hepatic production of IL-6, a marker of inflammation that, when found in high
concentrations in the plasma, has been correlated with increased chance of morbidity and
mortality in burn patients [101]. The next extensive capillary bed the blood encounters is
located within the lungs. Heightened IL-6 levels and bacterial byproducts that either
directly enter the bloodstream or enter the lymph are postulated as a mechanism behind
exacerbated pulmonary inflammation that is observed after a mouse model of
intoxication and injury [99] and may highlight why the lungs are one of the first organs to
fail [84].
Burn injury-induced lung apoptosis
Pulmonary inflammation after intoxication and injury associated with similar
pulmonary characteristics to ARDS in humans, including increased neutrophil
infiltration, capillary permeability and pulmonary edema [83, 102, 103]. Our laboratory
and others have established the adverse effect intoxication and injury has on lung tissue
[99, 104-107]. We have found elevated levels of alveolar wall thickening, neutrophil
accumulation, neutrophil chemokines KC and MIP-2, and increased pro-inflammatory
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cytokine IL-6 levels, relative to either ethanol exposure or burn injury alone [99, 104107] (Figure 2). The increase in bacteria, LPS and IL-6 into the blood and lymph is likely
a source of heightened pulmonary inflammation [108, 109]. As described above, AMs
help coordinate inflammatory processes in the lungs, but their role and activation state in
pulmonary inflammation after intoxication and injury is not known.
Another feature of ARDS is the increased apoptosis of epithelial cells in the lung
tissue, described in both humans and in mouse models [110-112]. Not surprisingly, burn
injury is associated with increased apoptosis in both lymphoid and parenchymal tissue,
including the thymus, spleen, and lungs [113-115]. Mesenteric lymph nodes have also
been highly postulated as likely source of gut-derived factors that initiate inflammation in
the lungs after burn injury [115, 116]. In a rodent model of 40% TBSA scald injury, an
increase in apoptotic cells in the lungs was found at 3 h, but a division of the mesenteric
lymph prior to burn injury decreased lung apoptosis at this time point, in comparison to
burn injured control counterparts [116]. This further supports the hypothesis that systemic
inflammatory mediators are responsible for increased pulmonary inflammation after burn
injury. In contrast, other studies have assessed apoptosis in the lungs at 3 and 8 h after a
20% scald injury in mice, but have found varying results on the presence of apoptotic
cells in the lung tissue [113, 114, 117]. Fukuzuka et al. reported an increase in apoptosis
in the thymus and spleen 3 and 24 h after burn injury, but not in the lungs and liver [113,
114]. Using various methods to detect apoptosis, including terminal deoxynucleotidyl
transferase-dUTP nick end labeling (TUNEL) staining, caspase-3 activity and mRNA
levels of TNFα and Fas ligand (FasL), their results suggested that the apoptosis observed
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Figure 2: Pulmonary inflammation after intoxication and injury. In steady-state
conditions, CD11c+Siglec-F+CD206+(CD11b-) AMs maintain tolerance and suppress
inflammatory responses through inhibitory receptors SIRPα,that binds SP-A and SP-D,
and mannose receptor CD206. As a result of heightened levels bacteria/LPS and IL-6 in
the blood stream after intoxication and injury, there is increased alveolar wall thickening,
neutrophil accumulation in the interstitium and an increase in neutrophil chemoattractants
KC and MIP-2, and IL-6 in lung tissue. The activation state and mediators produced by
AMs and their role in inflammation after intoxication and injury had not been
determined. Co-illustration credit to C.L. Shults
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in the lymphoid organs was a result of increased caspse-3 activity and was not
dependent on LPS or TNFα. Another study examined apoptosis in the lung at 8 h postburn injury and found at this time point there was an increase in caspase-3 activity, but
not in TUNEL+ cells in lung tissue [117]. The range of results of these studies are likely
due to differences in the model of burn injury, as well as the methods of apoptotic cell
detection. Of note, these studies failed to identity the cell type undergoing apoptosis in
any of the organs, including the lung. Since both AMs and epithelial cells are regulators
of neutrophil recruitment and AMs are also key organizers of resolving inflammation, the
fate of both of these cells after intoxication and injury is equally important.

Mesenchymal stem cells
Therapeutic agents in lung injury
Bone marrow-derived mesenchymal stem cells (MSCs) are a multipotent
population of stromal cells that are capable of differentiating into osteoblasts,
chondrocytes and adipocytes [118]. In addition to their differentiating properties, they
have been characterized as modulators of acute inflammation by virtue of their ability to
influence the phenotype of macrophages [119]. Exogenous MSC interaction with
macrophages and their release of paracrine soluble factors have been shown to suppress
inflammation and polarize macrophages into an M2, anti-inflammatory phenotype [119123]. Many studies suggest that the intravenous administration of MSCs results in the
entrapment of MSCs within the lungs [124-126]. Due to their large size, MSCs become
trapped within the pulmonary vasculature with only a fraction of these cells passing
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through and migrating to other organs. Specifically, intravenous administered MSCs
have been shown to localize in the lungs and interact with AMs, stimulating AM release
of IL-10 [121]. This property characterizes MSCs as a useful therapeutic in acute lung
injury.
Thus far, MSC therapy in burn injury has been focused on wound repair, where
MSCs are administered near the site of injury [127-130]. Xue et al. demonstrated the
plasticity of MSCs to differentiate into tissue-specific cells and to promote accelerated
wound healing, while others have shown an increase in neoangeogenesis and a decrease
in cellular infiltration at the wound site [130, 131]. Alternative routes of MSC
administration and their therapeutic applications is an understudied field in burn research
[129], but their anti-inflammatory properties and the ease of which they lodge in the lung
after intravenous injections, suggests they would be beneficial to attenuating pulmonary
inflammation after burn injury.
In summary, maintaining lung function after intoxication and burn injury is
critical to promoting survival in burn patients. AMs are key orchestrators in both pro- and
anti-inflammatory responses in the lung and their role in promoting the resolution of
inflammation is necessary for the restoration of lung homeostasis. A disruption in the
balance of this function can result in excessive inflammatory mediators and injury to the
lung tissue, including damage to the alveolar-capillary interface and gas exchange.
Therapeutic agents that specifically target AMs and their function in reducing
inflammation would be beneficial to the indirect lung damage amassed after burn injury.
Mesenchymal stem cell’s ability to localize to the lungs and influence an anti-

24
inflammatory activation profile by AMs, underline MSCs as a promising therapeutic to
reduce inflammatory responses in the lung. Deciphering if MSCs can attenuate
pulmonary inflammation after intoxication and injury will highlight the potential benefits
of MSCs in other models of trauma injury and systemic inflammation.

CHAPTER 3
IMPAIRED RESPIRATORY FUNCTION PARALLELS HEIGHTENED
PULMONARY INFLAMMATION AFTER EPISODIC BINGE ETHANOL
INTOXICATION AND BURN INJURY
Abstract

Clinical data indicate that cutaneous burn injuries covering greater than ten
percent total body surface area are associated with significant morbidity and mortality,
where pulmonary complications, including ARDS, contribute to nearly half of all patient
deaths. Approximately 50% of burn patients are intoxicated at the time of hospital
admission, which increases days on ventilators by three-fold, and doubles length of
hospital admittance, compared to non-intoxicated burn patients. The most common
drinking pattern in the United States is binge drinking, where one rapidly consumes
alcoholic beverages (4 for women, 5 for men) in 2 hours and an estimated 38 million
Americans binge drink, often several times per month. Experimental data demonstrate a
single binge ethanol exposure prior to scald injury, impairs innate and adaptive immune
responses, thereby enhancing infection susceptibility and amplifying pulmonary
inflammation, neutrophil infiltration, and edema, and is associated with increased
mortality. Since these characteristics are similar to those observed in ARDS burn
patients, our study objective was to determine whether ethanol intoxication and burn
injury and the subsequent pulmonary congestion affects physiological parameters of lung
25
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function using non-invasive and unrestrained plethysmography in a murine model
system. Furthermore, to mirror young adult binge drinking patterns, and to determine the
effect of multiple ethanol exposures on pulmonary inflammation, we utilized an episodic
binge ethanol exposure regimen, where mice were exposed to ethanol for a total of 6 days
(3 days ethanol, 4 days rest, 3 days ethanol) prior to burn injury. Our analyses
demonstrate mice exposed to episodic binge ethanol and burn injury have higher
mortality, increased pulmonary congestion and neutrophil infiltration, elevated neutrophil
chemoattractants, and respiratory dysfunction, compared to burn or ethanol intoxication
alone. Overall, our study identifies plethysmography as a useful tool for characterizing
respiratory function in a murine burn model and for future identification of therapeutic
compounds capable of restoring pulmonary functionality.
Introduction
Burn injury is associated with significant morbidity and mortality, with greater
than 10% of patients succumbing to their injuries when the burn size exceeds 10% of
their total body surface area [82]. Clinical data suggest that 42% of the mortality
observed in burn patients is due to pulmonary complications [85, 86]. Severe burn, even
in the absence of inhalation injury, is a common predisposing factor for the development
of Acute Respiratory Distress Syndrome (ARDS) [83, 84]. ARDS is associated with rigid
lungs, hypoxemia, and bi-lateral infiltrates in chest radiographs [132]. Overall,
respiratory dysfunction in burn patients is characterized by shallow breathing and fluid
accumulation in the lung interstitium, leading to heightened vascular resistance and an
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increased effort to breathe [84, 86]. A net result of insufficient gas exchange underlies
the large percentage of burn fatalities due to pulmonary complications.
Binge alcohol drinking is an increasingly prevalent activity, affecting an
estimated 38 million adults in the United States [133]. It is characterized by either the
number of alcoholic drinks one consumes in 2 hours (4 for women, 5 for men) or by a
blood alcohol concentration of 0.08%. Interestingly, approximately 50% of burn patients
are under the influence of alcohol at the time of hospital admission [88, 89]. Intoxicated
burn patients have three times as many days on ventilators and an overall twice as long
hospital stay compared to burn patients who were not intoxicated [89, 134]. This leads to
an increased risk of pulmonary complications that predisposes burn patients to multiple
organ failure, with the lungs preceding all other organs, as well as a higher chance of
mortality [90, 91]. Notably, the vast majority of intoxicated burn patients are binge
drinkers and not chronic dependent drinkers [59, 135, 136]. Experimental models of
binge alcohol intoxication and burn injury have demonstrated alterations in innate and
adaptive immunity that result in the marked immune dysfunction, greater susceptibility to
infection, and amplified pulmonary inflammation [104-106, 137-143]. Previously, our
laboratory established that in a mouse model of single-dose binge ethanol exposure and
burn injury there is amplified neutrophil infiltration, alveolar wall thickening, and edema
in the lungs when alcohol precedes burn injury [99, 104-107]. Since ARDS is associated
with similar pulmonary characteristics in humans, including increased neutrophil
infiltration, capillary permeability and pulmonary edema [83, 102, 103], the objective of
our study was to determine whether intoxication and burn injury, and the resulting
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histological pulmonary congestion, affects physiological parameters of lung function
using a murine model system.
In these studies, we used non-invasive and unrestrained plethysmography to
examine the impact of pulmonary congestion caused by burn injury on breathing patterns
and respiratory function [144]. This system measures the box flow, or the airflow in and
out of the plethysmography chamber as a result of respiration. Boyle’s law states that
there is an inverse relationship between the volume and pressure of a gas when the
temperature remains constant. Therefore, using Boyle’s Law and special algorithms, the
box flow can then be translated to the respiratory flow of an individual animal.
The Center for Disease Control (CDC) has reported 1 in 6 adults binge drink at
least 4 times a month. Additionally, weekend binge drinking is a pattern observed in
many cultures [145]. To mirror this drinking pattern, our laboratory used a mouse model
of episodic binge ethanol intoxication prior to burn injury (adapted from [146], [147150]) to assess respiratory physiology and gain an understanding of the effect of
intoxication on lung function after burn injury.
Overall, our analyses identify plethysmography as a useful tool for characterizing
respiratory function in a murine model of ethanol intoxication and burn injury. Our
studies demonstrate that episodic binge ethanol intoxication prior to burn causes
increased pulmonary neutrophil infiltration. The timing of neutrophil accumulation in the
lung parallels the heightened levels of lung neutrophil chemoattractants and is associated
with respiratory dysfunction, which likely contributes to diminished survival rates.
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Materials & Methods
Mice
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor,
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under
specific pathogen-free conditions in the Loyola University Chicago Comparative
Medicine facility. All experiments were conducted in accordance with the Institutional
Animal Care and Use Committee. Mice weighing between 22 to 27 g were used in these
studies.
Murine Model of Binge Ethanol and Burn Injury
A murine model of episodic binge ethanol intoxication and burn injury was
employed using intraperitoneal injections as described previously [138, 150, 151].
Animals were given ethanol (1.2g/kg) or saline vehicle at a dose designed to elevate the
blood alcohol concentration (BAC) to 150 mg/dL at 30 min after ethanol exposure [142].
This dose of 150 μl of 20% (v/v) ethanol solution or saline control was given daily for 3
days consecutively, mice were given 4 days without ethanol, and then given 3 additional
daily ethanol doses. Thirty minutes following the final ethanol exposure, when the BAC
was 150 mg/dl, the mice were anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine)
and their dorsums shaved. The mice were placed in a plastic template exposing 15% of
the total body surface area and subjected to a scald injury in a 92-95°C water bath or a
sham injury in room-temperature water [138]. The scald injury results in an insensate,
full-thickness burn [152]. The mice were then resuscitated with 1.0 ml saline and
allowed to recover on warming pads. All experiments were performed between 8 and 9
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am to avoid confounding factors related to circadian rhythms. Animals were either
euthanized at 24 hours or survival was measured out to 7 days post-injury.
Plethysmography
Pulmonary function was assessed at 24 hours post-injury by using barometric
plethysmography (Buxco Research Systems). BAC levels had returned to baseline
undetectable levels at this time point [76]. Mice were placed in an unrestrained whole
body barometric plethysmography chamber and allowed to acclimate to the environment
before lung function parameters [99] were recorded for 10 minutes on a breath-by-breath
basis. Enhanced pause (Penh), breath frequency (f), tidal volume (TVb) and minute
volume (MVb) were analyzed.
Histopathologic Examination of the Lungs
The upper right lobe of the lung was inflated with 10% formalin and fixed
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and
stained with hematoxylin and eosin (H&E). Sections were evaluated using light
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were
taken at 1000x magnification. To measure pulmonary congestion, photographs were
taken in a blinded fashion of 10 high power fields (400X) per animal and analyzed using
the Java-based imaging program ImageJ (National Institutes of Health, Bethesda, MD).
The images were converted to binary to differentiate lung tissue from air space and then
analyzed for the percent area covered by lung tissue in each field of view as described
previously [107]. Neutrophils were counted in a blinded fashion in 10 high power fields
(400X).
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Measuring Neutrophil Counts by Flow Cytometry
The upper left lung lobe was removed and cut into small pieces with a razor. The
lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA) and processed
using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml DNase I
(Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi Biotec),
according to manufacturer’s instructions. The homogenates were then filtered through 70
um nylon cell strainers to obtain a single cell suspension. Red blood cells were lysed
using ACK lysis buffer (Life Technologies, Grand Island, NY). Cells were counted using
trypan blue to exclude dead cells. To assess neutrophil numbers, 1x106 lung cells were
first incubated with anti-CD16/32 (clone 93,eBioscience, San Diego, CA) to block
unspecific binding to the Fcy II/III receptor. Cells were then immunostained with rat
anti-mouse antibodies: CD45 e780 (clone30-F11, eBioscience), CD11b e450 (clone
M1/70, eBioscience), and Ly6G (Gr-1) PE Cy7-conjugated (clone RB6-8C5,
eBioscience). Antibody incubation was carried out for 30 minutes at 4oC. Cells were
washed and fixed as described [143, 153]. Samples were run on a BD Fortessa cytometer
(BD Biosciences, San Jose, CA). Data analysis was performed using Flow Jo FCS
analysis software (Tree Star Inc., Ashland, OR).
Cytokine Analysis of Lung Homogenates
The right middle lung lobe was snap-frozen in liquid nitrogen and then
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine
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production using a BioPlex multiplex bead array. The results were normalized to total
protein using the BioRad protein assay (BioRad) [106, 107].
Statistical Analysis
Statistical comparisons were made between the sham vehicle, sham ethanol, burn
vehicle, and burn ethanol treatment groups. One-way analysis of variance (ANOVA) was
used with Tukey’s post-hoc test or Bonferroni Multiple Comparisons test and values were
considered statistically significant when p < 0.05. Data is reported as mean values ± the
standard error of the mean (SEM). The Gehan-Breslow-Wilcoxon test was used to
generate comparisons between burn groups in the survival study and Pearson’s
correlation test was used to generate the correlation coefficient between neutrophil
numbers and Penh, breath frequency, tidal volume, and minute volume.
Results
Binge Ethanol Intoxication Decreases Survival After Burn Injury
Mice exposed to episodic binge ethanol intoxication and burn injury were
monitored for survival out to 7 days post-injury. Both sham groups had 100% survival
regardless of ethanol intoxication (Figure 3). Survival of burn-injured mice exposed to
ethanol was significantly lower (48% survival) (p < 0.05) when compared to burn-injured
mice not exposed to ethanol (84% survival) (p < 0.05). Observed mortality in the
combined injury group occurred within 72 hours of injury, with 5% succumbing by 24
hours, 16% mortality between 24 and 48 hours and the majority of death, 31%, occurring
between 48 and 72 hours. This suggests there is a therapeutic window between time of
injury and 24 hours to potentially prevent mortality when ethanol precedes burn injury.
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Figure 3. Decreased survival of mice exposed to ethanol prior to burn injury. Mice were
exposed to ethanol or saline as a control for a total of 6 days (3 days ethanol, 4 days rest,
3 days ethanol) prior to burn injury and monitored for survival out to 7 days post-injury.
p < 0.05, burn ethanol compared to burn vehicle by Gehan-Breslow-Wilcoxon test. Data
were combined from 2 independent experiments and are expressed as percent survival.
N = 4 (sham groups), n = 10-19 (burn groups).
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Figure 4. Ethanol intoxication impairs post-burn lung function. Mice were placed in an
unrestrained whole body barometric plethysmography chamber and lung function
parameters were recorded for 10 minutes. Penh, p < 0.05 burn ethanol versus all groups,
p < 0.05 burn vehicle versus sham groups. Breath frequency, p < 0.05 burn ethanol versus
all groups, p < 0.05 burn vehicle versus sham groups. Tidal volume, p < 0.05 burn
ethanol compared to sham groups, p < 0.05 burn vehicle compared to sham groups.
Minute volume, p < 0.05 burn ethanol compared to sham groups, p < 0.05 burn vehicle
compared to sham groups. Data were combined from 2 independent experiments. Data
points shown as individual animals. N = 6-11 animals per group.
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Intoxication Reduces Lung Function in Mice Subjected
to Burn Injury
Lung function was assessed 30 minutes prior to animals being euthanized at 24
hours post-injury. Enhanced pause (Penh), a measure of bronchoconstriction and airway
resistance, revealed that animals that were intoxicated at the time of burn injury had an
average Penh of 8, compared to sham groups with a Penh of less than 1 and burn injury
alone with an average Penh of 3 (Figure 4A). When ethanol intoxication precedes burn
injury, this corresponds with an 8-fold increase in airway resistance, compared to sham
groups (p < 0.05), and a 2.5-fold increase, compared to burn injury alone (p < 0.05).
Moreover, our data reveal that animals with a Penh of 7 or above are at a greater risk for
mortality. The frequency of breaths per minute was also significantly decreased in both
burn groups. Burn injury alone had a 39% decrease in the average number of breaths per
minute compared to shams (p < 0.05), while intoxicated and burn-injured mice had a 59%
decrease compared to shams (p< 0.05) and a 33% decrease compared to burn alone (p <
0.05) (Figure 4B). Additionally, tidal volume, the amount of air that is inhaled and
exhaled in a single breath, was decreased in both burn groups compared to sham groups
(p < 0.05) (Figure 4C). Minute volume, the amount of air inhaled and exhaled per minute,
was also decreased in both burn groups (Figure 4D). Compared to shams, burn injury
alone had a 60% decrease in the amount of air per minute (p<0.05), while intoxicated and
burn-injured mice had an 80% decrease (p<0.05). Furthermore, combined injury had a
52% decrease compared to burn alone, though this did not reach statistical significance.
These data indicate burn injury alone induces abnormal breathing patterns, however,
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when intoxication precedes burn injury, there is a dramatic increase in airway resistance
and a pronounced reduction in lung function. Overall, intoxicated and burn injured
animals have a shallow, slower breathing rate than burn injury alone, indicative of overall
respiratory dysfunction.
Elevated Pulmonary Neutrophil Infiltration and Congestion
after Intoxication and Burn Injury
Similar to the single-dose binge ethanol and burn injury results previously
reported by our laboratory, [104-107] histochemical analyses of sectioned lung tissue
demonstrated that episodic binge ethanol intoxication prior to burn injury results in
increased cellularity and alveolar wall thickening 24 hours post-injury (Figure 5A-C).
Neutrophils were counted by light microscopy as previously described [104]. When
intoxication preceded burn injury, there was a 10-fold increase compared to sham groups
(p < 0.05) and an approximate 1.5-fold increase compared to burn alone (Figure 5B).
Additionally, these neutrophils were localized to the interstitium and not the alveolar
space. Pulmonary congestion was quantified using imaging software to measure the area
of lung tissue in 10 high power fields per animal and is reported as a percentage of the
entire field of view. Intoxicated and burn injured animals had a significant increase in
tissue area compared to all other groups (p < 0.05), correlating to a decrease in air space
and an increase in pulmonary congestion (Figure 5C). Notably, these changes were
isolated to the distal airways. There were no apparent changes in the larger airways.
To further demonstrate that neutrophils were the key cell type contributing to the
escalated cellularity, flow cytometry was performed. Flow cytometric analysis of cellular
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Figure 5. Episodic binge ethanol results in similar pulmonary congestion as single dose
binge ethanol and burn injury. Lungs were sectioned and stained with H&E and assessed
for cellular infiltration and alveolar wall thickening. A) Representative sections from
each treatment group are shown at 1000x. B) Neutrophils were counted by light
microscopy in H&E-stained lung sections 24 hours after intoxication and burn injury.
Data are shown as the total number of neutrophils in 10 high power fields (400x). C)
Quantification of pulmonary congestion 24 hours after injury. * p < 0.05 compared to
sham groups; # p < 0.05 compared to all groups. Data are presented as mean values ±
SEM. N = 3-6 animals per group.
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Figure 6. Ly-6G+CD11b+ neutrophils are elevated after episodic binge ethanol and burn
injury. Lung tissue was obtained 24 hours post-injury from all treatment groups. Tissue
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isolates. * p < 0.05 versus sham groups. Data are presented as mean of total neutrophils
from 100,000 lung cells per group ± SEM. N = 3-6 animals per group.
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subsets in the lung revealed dramatically increased CD45+CD11b+Ly6G+ neutrophil cell
counts in intoxicated and burn injured mice at 24 hours post-injury, compared to sham
and isolated burn injury alone (p < 0.05) (Figures 6A&B ). Mice exposed to the
combined insult had a 7-fold increase (p < 0.05) in neutrophil numbers when compared to
both sham groups and a 1.5-fold increase when compared to burn-injured animals
without ethanol intoxication, confirming that neutrophils contribute to increased
cellularity in the lungs of intoxicated and burn-injured mice.
It was also observed that the increase in the number of neutrophils corresponded
to an increase in Penh and decreases in breath frequency, tidal volume and minute
volume. Pearson’s correlation coefficient was used to determine if there was a linear
relationship between the number of infiltrating neutrophils and lung function
measurements. We found a positive correlation between the number of neutrophils and
Penh (r = 0.9597) and negative correlations between neutrophil numbers and breath
frequency (r = -0.9866), tidal volume (r = -0.9777) and minute volume (r = -0.9784).
These data emphasize the potential use of plethysmography as an instrument to determine
the effect of neutrophil accumulation in lung tissue on overall lung function.
Ethanol Intoxication Before Burn Injury Enhances Pulmonary KC and Macrophage
Inflammatory Protein - 2 (MIP-2) Levels
Since we observed increased neutrophil infiltration, we next sought to examine
levels of the neutrophil chemoattractants, KC and MIP-2. Similar to our single-dose
binge ethanol and burn injury findings [104-106], the upregulation of neutrophil
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Figure 7. Heighted pulmonary neutrophil chemokine KC and MIP-2 levels after episodic
binge ethanol and burn injury. Lung homogenates from all four treatment groups were
analyzed for levels of A) KC and B) MIP-2. * p < 0.05 versus sham groups; # p < 0.05
versus all treatment groups. Data are presented as the mean in picograms per milligram of
protein ± SEM. N = 3-6 animals per group.
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chemokines KC and MIP-2 highlight a mechanism behind the increase in pulmonary
neutrophil accumulation in episodic binge ethanol exposed and burn-injured mice (Figure
7). Combined injured animals had an 11-fold more KC than both sham groups (p < 0.05)
and 1.8-fold more KC than burn injury alone (Figure 7A). Additionally, MIP-2 was
significantly upregulated compared to all treatment groups, with a 6-fold increase in
MIP-2 compared to sham groups (p < 0.05) and a 2.5-fold increase compared to burn
injury alone (p < 0.05) (Figure 7B).
Summary
Intoxication at the time of burn injury increases bacterial translocation from the
intestines into the lymphatic system and bloodstream. Excessive levels of IL-6 and
endotoxins not removed by the liver may circulate to the vascular bed of the lungs and
initiate pulmonary inflammation and congestion [95-100]. Prior to this study, it was not
known how multiple doses of ethanol would affect burn-induced pulmonary
inflammation. Ethanol intoxication alone has been shown to suppress immune responses
in many organs, including the lungs [8, 75, 154, 155]. Whether episodic ethanol
intoxication before burn injury would yield heightened or diminished pulmonary
inflammatory effects had yet to be determined. It was also not known how intoxication
prior to injury affects lung function. Here, we have demonstrated that episodic binge
ethanol prior to burn injury causes heightened pulmonary inflammatory responses and
congestion, paralleling single-dose binge ethanol exposure. Importantly, we have found
that these histologic inflammatory responses cause physiological derangements in
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intoxicated and burn-injured animals, including increased airway resistance and
abnormal breathing patterns. These findings highlight an underlying mechanism
contributing to the drastic mortality rate observed in mice exposed to both ethanol and
burn injury.
In conclusion, these data emphasize the importance of immediate burn care
treatment within the few hours after injury, to stabilize breathing patterns and to maintain
respiratory function, especially when patients are intoxicated at the time of injury. Noninvasive, unrestrained whole-body plethysmography will be a useful tool in future animal
studies to help identify therapeutic reagents that can improve respiratory function in all
burn patients.

CHAPTER 4
LOSS OF ALVEOLAR MACROPHAGES CORRELATES WITH ELEVATED
NEUTROPHIL NUMBERS IN THE LUNG FOLLOWING INTOXICATION AND
BURN INJURY
Abstract
Clinical evidence reveals that half of all burn patients brought to the emergency
department are intoxicated at the time of injury. This combined insult results in
amplified neutrophil accumulation in the lung and pulmonary edema, with an overall
increased risk of lung failure and mortality, relative to either insult alone. We and others
believe that this excessive pulmonary inflammation, that also parallels decreased lung
function, is attributed, in part, to AM function. Restoration of lung tissue homeostasis is
dependent on the eradication of neutrophil infiltration and removal of apoptotic cells,
both major functions of AMs. With lung function impairment causing a likely decrease
in gas exchange, we chose to examine the fate of these multi-functional cells. Thirty
minutes after binge ethanol intoxication, mice were anesthetized and given a 15% total
body surface area dorsal scald injury. At 24 h, we found a 50% decrease in the number of
AMs (p<0.05) and 7-fold more TUNEL+ apoptotic cells (p<0.05) in the lungs after
intoxication and injury, relative to control. Analysis of annexin V and propidium iodide
on BAL AMs revealed a 2-fold increase in the percent of dead AMs (p<0.05) and a 3fold increase in the percent of apoptotic AMs, above that of controls. Interestingly, AMs
that were recovered from intoxicated and injured mice had 5-fold more phagocytic AMs,
43
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relative to AMs from controls (p<0.05) and also spontaneously produced 5-fold more
tumor necrosis factor α than controls (p<0.05). Intratracheal clodronate liposome
reduction of AMs correlated with a rise in lung neutrophil numbers in intoxicated and
injured mice, relative to empty liposome treatment. In summary, these data support AMs
role in managing neutrophil numbers and inflammation in the lung after intoxication and
burn injury and the significant loss of AMs may delay resolution of inflammation,
resulting in the elevated mortality rate observed in intoxicated and burn-injured patients.
Introduction
ARDS is a common morbidity among severe burn-injured patients, with or
without inhalation injury [83, 84]. Infiltration of inflammatory cells and increased
pulmonary edema lead to impaired gas exchange and increase the risk of pulmonary
failure [83, 102, 103], resulting in an estimated 42% of the mortality after burn injury
linked to pulmonary complications [85, 86]. Alcohol is the most abused substance in the
United States [133] and is a factor in many unintentional injuries, including burn injuries,
making alcohol the 3rd leading cause of preventable death [63]. The consumption of
alcohol prior to injury can lead to worsened outcomes and clinical data suggests that
nearly half of all burn patients that are taken to the emergency room have a positive blood
alcohol content [88, 89, 92]. Notably, of those who consume alcohol, the majority of the
drinkers are binge drinkers, not chronic dependent drinkers [59].
We and others have established in a mouse model of intoxication and burn injury
that lung inflammation mirrors similarities to the characteristic pathology of ARDS.
Within the distal airways of the lung we found increased alveolar wall thickening and
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neutrophil accumulation into the interstitium, that paralleled heightened levels of
neutrophil chemokines KC and MIP-2, as well as pro-inflammatory cytokine IL-6 levels,
relative to either ethanol exposure or burn injury alone [99, 104-107, 156]. The increased
number of neutrophils infiltrating into the lung interstitium correlated to a decrease in
lung function. This pulmonary inflammation therefore may have causative role in
increased mortality associated with alcohol exposure prior to burn injury [156].
AMs are the lungs first line of defense against inhaled particles or pathogens and
elegantly coordinate the on-set and resolution of inflammation [157]. The transition from
steady-state healthy conditions to an inflammatory state is made possible by the plasticity
of macrophages to readily activate into a reversible inflammatory profile as either a proinflammatory, M1 macrophage or an anti-inflammatory, M2 macrophage, depending on
mediators present within the microenvironment. AMs have a phenotype distinct from
other tissue-resident macrophage populations and can be characterized as CD11c+CD11bSiglec-F+F4/80+, with constitutive expression of mannose receptor CD206 and low to
negative expression of major histocompatibility complex class II (MHC II) [20, 21, 158].
The upregulation of specific receptors on AMs can define AM function in different stages
of inflammation. Scavenger receptor MARCO is described as a marker of proinflammatory M1 macrophages and aids in the clearance of apoptotic cells (termed
efferocytosis) [159] [32, 160]. Additionally, CD11b is also an important receptor in
efferocytosis [161]. During the resolution phase of inflammation, CD206 has been
characterized as a marker of a M2, anti-inflammatory profile [34, 162-164], thus an up or
down regulation of CD206 on AMs from baseline levels could suggest a transition to an
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activated profile. Lastly, M2 marker interleukin (IL)-10 receptor (IL-10R) on AMs is
also important in regulating inflammation, where the ligation of IL-10R indirectly
inhibits the TLR4 signaling pathway, decreasing pro-inflammatory cytokine release [33].
During an inflammatory response in the lung, excessive levels of mediators
produced by macrophages or neutrophils can result in tissue damage if not properly
regulated [41]. Therefore, lung inflammation needs to be a highly monitored process.
Resolution is achieved through pathogen clearance, downregulation of neutrophil
chemokines and the removal of apoptotic cells, such as neutrophils, all potential functions
AMs [165]. Specifically, macrophage efferocytosis can down regulate NO release and
upregulate IL-10 and TGFβ [43-46]. Burn injury and apoptosis studies revealed an
increase in apoptosis in both lymphoid and parenchymal tissue, including the thymus,
spleen, and lungs, at 3 and 8 h post-injury; however, the specific cell subsets undergoing
apoptosis were not analyzed in these studies [113-115]. Moreover, another feature of
ARDS is the increase in apoptosis of epithelial cells in the lung tissue, described in both
humans and in mouse models [110-112]. The role of AMs in coordinating on-going
inflammation and the timely initiation of resolution emphasizes that the activation profile
and fate of AMs during inflammation is critical to restoring lung homeostasis.
Since intoxication at the time of injury results in greater pulmonary complications
and mortality rates than burn injury alone, we chose to examine the role of AMs in only
intoxicated and burn-injured mice, in comparison to sham vehicle control. In this study,
we examined the role of AMs in pulmonary inflammation after intoxication and burn
injury. Our results suggest that at 24 h after injury there is a 50% reduction in the number
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of AMs present within the lung tissue, but AMs that were isolated from the tissue
exhibited an efferocytosis function. Upregulation of MARCO and CD11b are consistent
with findings of increased efferocytosis by AMs. Additionally, we found heightened
numbers of apoptotic cells in the lungs and identified AMs as at least a small population
of these apoptotic cells. Finally, clodronate liposome reduction of AMs prior to
intoxication and injury correlated with an increase in neutrophil numbers, in comparison
to intoxicated, injured and empty liposome treated mice. We conclude that AMs role in
clearing apoptotic cells and limiting the number of neutrophils in the lung is subdued by
an increase in the apoptosis of AMs.
Materials & Methods
Mice
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor,
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under
specific pathogen-free conditions in the Loyola University Chicago Comparative
Medicine facility. All experiments were conducted in accordance with the Institutional
Animal Care and Use Committee. Mice weighing between 22 to 27 g were used in these
studies.
Murine Model of Binge Ethanol and Burn Injury
A murine model of single dose binge ethanol intoxication and burn injury was
employed using oral gavage as described previously [138, 150, 151]. Animals were given
400 μl of 10% (v/v) ethanol solution (1.6 g/kg) or water control by gavage at a dose
designed to elevate the blood alcohol concentration to 150 mg/dL at 30 min after ethanol
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exposure [142]. Thirty minutes following the ethanol exposure, the mice were
anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine) and their dorsum shaved. The
mice were placed in a plastic template exposing 15% of the total body surface area and
subjected to a scald injury in a 92-95°C water bath or a sham injury in room-temperature
water [138]. The scald injury results in an insensate, full-thickness burn [152]. The mice
were then resuscitated with 1.0 ml saline and allowed to recover on warming pads. All
experiments were performed between 8 and 9 am to avoid confounding factors related to
circadian rhythms. Animals were euthanized at 24 hours.
Histopathologic Examination of the Lungs
The upper right lobe of the lung was inflated with 10% formalin and fixed
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and
stained with hematoxylin and eosin (H&E). Sections were evaluated using light
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were
taken at 400x magnification. Neutrophils were counted in a blinded fashion in 10 high
power fields (400X).
Cytokine Measurements in Lung Homogenates
The right middle lung lobe was snap-frozen in liquid nitrogen and then
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine
production using a BioPlex multiplex bead array [106, 107]. The results were normalized
to total protein using the BioRad protein assay (BioRad).
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Isolation of Cells from Lung Tissue
The upper left lung lobe was removed and cut into small pieces with a razor. The
lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA) and processed
using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml DNase I
(Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi Biotec),
according to manufacturer’s instructions. The homogenates were then filtered through 70
um nylon cell strainers to obtain a single cell suspension [21]. Red blood cells (RBCs)
were lysed using ACK lysis buffer (Life Technologies, Grand Island, NY). Cells were
counted using trypan blue to exclude dead cells.
Bronchoalveolar Lavage
The lungs of mice were lavaged 5 times with 1 mL of cold PBS to obtain the
bronchoalveolar lavage (BAL) fluid [76]. All lavage washes were pooled per animal.
Cells were spun at 1200 rpm for 3 min at 4°C. RBCs were lysed using ACK lysis buffer,
washed and spun at 1200 rpm for 3 min at 4°C. Cells were resuspended up to 400ul in
PBS and counted using a hemocytometer. Cells were either analyzed by flow cytometry,
cultured in chamber slides or cytocentrifued onto slides.
Flow Cytometry Analysis of Alveolar Macrophages
To assess alveolar macrophages, 1x106 lung cells or 1x105 BAL cells were first
incubated with anti-CD16/32 (clone 93,eBioscience, San Diego, CA) to block unspecific
binding to the Fcy II/III receptor. Cells were then immunostained with rat anti-mouse
antibodies: CD11c APC-eFluor 780 (clone N418, eBioscience), CD11b eFluor 450 (clone
M1/70, eBioscience), Siglec-F PE-CF594 (clone E50-2440, BD Biosciences, San Jose,
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CA), CD206 PE (clone C068C2, Biolegend, San Diego, CA), Ly-6G (Gr-1) PE-Cy7
(clone RB6-8C5, eBioscience), F4/80 APC (clone BM8, eBioscience), MHC II (I-A/I-E)
V500 (clone M5/114.15.2, BD Biosciences), TLR4/MD-2 APC (clone MTS510,
eBioscience), IL-10R PE (clone 1B1.3a, BD Biosciences), MARCO FITC (clone ED31,
AbD Serotec, Raleigh, NC) [21]. Antibody incubation was carried out for 30 minutes at
4oC. Cells were washed and fixed as described [143, 153]. MHC II was used as a M1
marker and CD206 was used a M2 marker [21]. In separate experiments, apoptosis and
cell death was also assessed on BAL alveolar macrophages using an Alexa Fluor® 488
Annexin V/Dead Cell Apoptosis Kit (Life Technologies), according to the
manufacturer’s protocol. Samples were run on a BD Fortessa cytometer (BD
Biosciences). Data analysis was performed using Flow Jo FCS analysis software (Tree
Star Inc., Ashland, OR). BAL alveolar macrophages were also analyzed for apoptosis
using a CellEvent™ Caspase-3/7 Green Flow Cytometry Kit (Life Technologies),
according to manufacturer’s protocol, in combination with Siglec-F PE (BD
Biosciences). Samples were run on an Amnis ImageStreamX flow cytometer (Millipore,
Billerica, MA) and analyzed on IDEAS software (Amnis Millipore, Seattle, WA).
Intracellular Staining of iNOS and ARG1
BAL cells were isolated and plated at 50,000 cells in 200ul complete medium (RPMI
without phenol red with 10% FBS and 5% penicillin-streptomycin-glutamine (PSG)) per
chamber slide well. Slides were incubated 1.5 h at 37°C to let macrophages adhere.
Supernatant was removed and stored at -80°C for future cytokine analysis studies using a
BioPlex multiplex bead array. Cells fixed with 4% PFA for 20 minutes at room
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temperature and then permeabilized with 0.2% Triton X-100 for 30 min at 37 C,
followed by 10 min at room temperature. To block non-specific binding, cells were
incubated with superblock for 5mins at room temperature and stained overnight 4oC with
mouse anti-mouse Arginase 1 (ARG1) (Abcam, Cambridge, MA) and rabbit anti-mouse
inducible nitric oxide synthase (iNOS) (Abcam). Secondary antibodies donkey antimouse IgG 488 (Abcam) and donkey anti-rabbit IgG 594 were applied for 1.5 h at room
temperature. Slides were air dried and mounted with Prolong Gold Dapi (Life
Technologies).
Analysis of Alveolar Macrophages
BAL cells were cytocentrifuged onto slides using a Shandon Cytospin 2. Briefly,
50,000 BAL cells were resuspended in total of 200ul PBS and cytocentrifuged at
400RPM for 5 min. Slides were stained with HEMA 3 differential stain and analyzed
using light microscopy (EVOS, Life Technologies). Photographs of cells were taken at
100x and 400x magnification. Phagocytic alveolar macrophages were counted in a
blinded fashion in 5 high power fields (400X). Additionally, cytocentrifuged cells were
stained with rabbit anti-mouse active-caspase 3 antibody (Abcam), followed by
secondary antibody donkey anti-rabbit IgG 594. Briefly, cells were fixed with 4%
paraformaldehyde (PFA), permeabilized with 0.1% Triton-100x in 2% BSA and blocked
with 10% normal donkey serum. In a humidity chamber, cells were incubated with rabbit
anti-mouse active-caspase 3 overnight at 4oC, followed by donkey anti-rabbit IgG 594 for
1 h at room temperature. Slides were air dried and mounted with Prolonged Gold Dapi
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(Life Technologies). Immunofluorescent photographs were taken at 1000x using a
Zeiss AxioVert microscope.
TUNEL Immunofluorescent Staining in Lung Tissue
The upper right lobe of the lung was inflated with 10% formalin and fixed
overnight as described previously embedded in paraffin, sectioned at 5 μm [104]. A
Click-it® Plus in situ terminal deoxynucleotidyl transferase-dUTP nick end labeling
(TUNEL) Alexa Fluor 488 assay was performed according to manufacturer’s protocol
(Life Technologies) to detect apoptotic cells. Lung sections were evaluated using
fluorescent microscopy (EVOS, Life Technologies) and photographs were taken at 100x
and 400x. TUNEL+ cells were counted in a blinded fashion in 10 low power fields
(100X) using a Java-based imaging program ImageJ (National Institutes of Health,
Bethesda, MD). The images were converted to binary to differentiate TUNEL+ from nonfluorescent cells and then analyzed for the number of TUNEL+ cells in each field of view.
Alveolar Macrophage Immunofluorescent Staining for Siglec-F
The upper left lobe was inflated with 25% optimal cutting temperature (OCT)
freezing medium, frozen in OCT over dry ice and stored at -80oC. Tissue was
cryosectioned at 6 μm and sections were air-dried for 1 hour at room temperature. Slides
were fixed for 5 min in 4% PFA and blocked with superblock for 5 min. In a humidity
chamber, sections were incubated overnight at 4oC with rat anti-mouse purified Siglec-F
(Clone E50-2440, BD Biosciences), followed by secondary antibody goat anti-rat Alexa
Fluor® IgG (H+L) 555 (Life Technologies) for 1 h at room temperature. Slides were air
dried and mounted with prolonged dapi gold (Life Technologies). For double staining of
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Siglec-F and TUNEL, slides were first stained for Siglec-F, followed by TUNEL
staining, according to the manufacturers protocol (Life Technologies). Sections were
evaluated using immunofluorescent microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA)
and photographs were taken at 400x and 1000x magnification.
Depletion of Alveolar Macrophages
AMs were depleted using clodronate encapsulated liposomes (Encapsula
NanoSciences, Brentwood, TN). Briefly, mice were anesthetized (100 mg/kg ketamine
and 10 mg/kg xylazine) and given intratracheal administration (75ul) of clodronate
liposomes or control, empty liposomes. Three days after clodronate administration, mice
underwent our model of binge ethanol and burn injury and were euthanized at 24 h after
injury.
Serum Measurements
Blood was collected via cardiac puncture and the serum was isolated at stored at
-80°C. Serum aliquots were used to measure IL-6 by enzyme linked immunosorbent
assay (ELISA) (BD Biosciences, Franklin Lakes, NJ).
Plethysmography
Pulmonary function was assessed at 24 hours post-injury by using barometric
plethysmography (Buxco Research Systems). BAC levels had returned to baseline
undetectable levels at this time point [76]. Mice were placed in an unrestrained whole
body barometric plethysmography chamber and allowed to acclimate to the environment
before lung function parameters [99] were recorded for 10 minutes on a breath-by-breath
basis. Enhanced pause (Penh), breath frequency (f), tidal volume (TVb) and minute
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volume (MVb) were analyzed.
Statistical Analysis
Statistical comparisons were made between the sham vehicle and burn ethanol
treatment groups. Unpaired T-test was used and values were considered statistically
significant when p < 0.05. Data is reported as mean values ± the standard error of the
mean (SEM).
Results
Alterations In Alveolar Macrophage Populations After Intoxication And Injury
We confirmed the phenotype of AMs obtained through either enzymatic
dissociation of lung tissue or from the BAL fluid (see Appendix A). Our observations of
a decrease in the density of the AM population (Appendix A, Figure 31G), but an
increase in the granularity of AMs that are present (Appendix A, Figure 32D) after
intoxication and injury supported the examination of the absolute number and activation
profile of AMs. Quantification of AMs revealed that in intoxicated and injured mice there
was a 50% decrease in the number of AMs from dissociated lung tissue (p<0.05) (Figure
8A), as well as a 50% decrease in the number of BAL cells recovered from BAL fluid
(p<0.05) (Figure 8B), in comparison to sham mice. While it was not significant, there
was a 1.5-fold increase in the number of CD11c+CD11b+F4/80loSiglec-F+ intermediate
AMs after intoxication and injury (Figure 8C). Expression of surface receptors using
mean fluorescence intensity (MFI) revealed no significant change in the level of MHC II
(Figure 9A). This was not surprising since we would not expect antigen presentation
without an active lung infection in the airways. There was also no significant change in
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Figure 8: A) Decreased number of CD11c+CD11b-Siglec-F+ AMs after intoxication and
injury. Data are representative of cell counts per 350,000 total lung cells. B) Number of
cells recovered from BAL fluid after intoxication and injury. Lungs were lavaged 5x
with a total of 5mL of PBS. Total BAL cells were counted and presented as the average
number of total cells recovered from BAL. C) Number of CD11c+CD11b+F4/80loSiglecF+ intermediate AMs in dissociated lung tissue. Data are representative of cell counts per
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N=4-6 animals per group.
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the level of TLR4/MD-2 at 24 h after injury (Figure 9B). However, scatterplot
representation of TLR4/MD-2 MFI on AMs from individual intoxicated and injured mice
showed variability in its expression, with a trend toward upregulated TLR4/MD-2,
further confirmed by a slight increase in the histogram overlay. This suggests that AMs
may be activated by TLR4 ligands, such as LPS or endotoxins. We also observed a
significant upregulation of MARCO and CD11b (p <0.05), receptors that are both
important for efferocytosis (Figure 9 C&D). In contrast, there was no change in the
expression of M2 markers CD206 or IL-10R (Figure 9 E&F).
These phenotypic changes towards an inflammatory profile led us to examine the
intracellular levels of additional M1 and M2 markers, iNOS and ARG1. BAL cells
isolated at 24 h post-injury were briefly cultured in chamber slides and
immunofluorescent staining was used to evaluate these markers (Figure 10A). Results
indicated there was not an increase in iNOS expression in comparison to ARG1, a
phenotypic characteristic of pro-inflammatory macrophages (Figure 10B&C). iNOS has
been shown to be important in killing intracellular bacteria [166], therefore the absence of
an active lung infection in our model likely would not elicit an upregulation of iNOS by
AMs.
Increased lung apoptosis 24 h after intoxication and injury
AMs comprise only 10% of the total cells found in the alveoli, yet their function
in maintaining a pathogen-free environment is critical for lung homeostasis. The loss of
AMs after intoxication and injury led us to investigate the fate of these regulatory cells 24
h post-injury, predicting that the decrease in AMs correlated to an increase in AM
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apoptosis. Using immunofluorescent TUNEL staining, we assessed lung tissue for
apoptotic cells. We observed numerous fluorescent punctate cells in lung tissue from
intoxicated and injured mice (Figure 11A) quantification revealed that this group had 7fold more apoptotic cells than sham mice (p<0.05) (Figure 11B). We also stained lung
tissue from intoxicated and injured mice for both Siglec-F and TUNEL to determine if
AMs were a population of apoptotic cells, but we failed to observe co-localization of
Siglec-F+ and TUNEL+ cells in lung tissue (Figure 12A). Using an imaging flow
cytometer, we examined Siglec-F+ BAL AMs for apoptosis marker caspase-3/7 and
observed Siglec-F+ cells were negative for caspase-3/7 expression. Cells with caspse-3/7lo
expression exhibited low to no surface expression of Siglec-F, but potentially had
cytoplasmic expression of Siglec-F. Furthermore, caspase-3/7hi cells did not express
Siglec-F (Figure 12B-D). Since > 92% BAL cells are AMs [8], this could suggest AMs
lose Siglec-F as they undergo apoptosis and this may be the reason why we are unable to
detect co-localization of the Siglec-F marker and TUNEL in lung tissue. At this time, we
have yet to use other AM markers to identify TUNEL+ cells in lung tissue. The imaging
flow cytometry data did not reveal a difference in caspase-3/7+ cells between treatment
groups, but since this cytometer acquires images of cells, analysis had to be limited to
only 500-1000 cells per sample. The literature also suggests there is not a universal
marker for apoptosis and it is recommended apoptosis should be measured using various
methods [167].
BAL cells were next analyzed for apoptosis marker, annexin V and dead cell
marker, propidium iodide (Figure 13A&B). Intoxicated and injured animals had a 2-fold
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± SEM. N=4 animals per group.
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increase in percent of dead cells (p<0.05) (Figures 13C) and a 3-fold increase in the
percent of apoptotic cells (Figures 13D), in comparison to sham mice. Overall,
intoxicated and injured animals had a 2.5-fold higher incidence of dead or apoptotic BAL
cells (p<0.05), in comparison to sham animals (Figures 13E). This translated to 10% of
BAL cells from sham animals being lost to cell death or apoptosis, while intoxicated and
injured mice had 25% lost to cell death or apoptosis. With the BAL fluid containing >
92% AMs, regardless of treatment group, these data suggest AMs are susceptible to
apoptosis after intoxication and injury.
TUNEL+ cells were also quantified in tissue that had been lavaged to obtain the
BAL fluid, in comparison to non-lavaged lung tissue. If alveolar macrophages were
undergoing apoptosis, then we would predict to see a decrease in the number of apoptotic
cells after the tissue had been lavaged in intoxicated and injured mice. Interestingly,
there was no difference in the number of TUNEL+ cells between total lung tissue and
lavaged lung tissue (data not shown), but flow cytometry analysis of lavaged tissue
showed lavaging the tissue only removed 5% of AMs, in comparison to non-lavaged
lung. The literature suggests that the majority of AMs are sessile and are not easily
removed from the lungs after lavage [10]. In our laboratory, BAL fluid consistently
yields less than 200,000 AMs in sham mice and less than 100,000 cells from intoxicated
and injured mice. With only 1-2 million total AMs in mouse lungs, the removal of less
than 100,000 cells calculates to the isolation of only 5-10% of total AMs in the lungs.
This further supports our flow cytometry data that lavaging the lungs only removed 5%
of AMs, therefore, it is not unusual that the removal of BAL cells from lung tissue would
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not yield major differences in the number of apoptotic cells, especially since only 25%
of the removed cells would be dead or apoptotic. Taken together, these data suggest that
AMs are only one population of the TUNEL+ cells. Other cells undergoing apoptosis in
the lungs are likely epithelial and endothelial cells.
Active efferocytosis by AMs
Phagocytic removal of apoptotic cells is an important function of alveolar
macrophage to restore lung tissue to homeostasis. Loss of AMs and an increase in
apoptosis by non-AM cell populations led us to question whether the increase in
apoptotic cells was due to the lack of AMs available to clear apoptotic cells. First, we
determined whether AMs actively efferocytosed apoptotic cells. Since AMs from
intoxicated and injured mice displayed more granularity and upregulated efferocytosismediating receptors, we predicted AMs would be more phagocytic. Analysis of the
morphology of AMs from both treatment groups revealed that sham animals had healthy,
uniform alveolar macrophages (Figure 14A&C), while AMs from intoxicated and injured
animals had more phagocytic alveolar macrophages (Figure 14 B&D-F, arrows). The
appearance of phagocytic AMs ranged from small translucent vesicles (Figure 14D) to
larger bodies within AMs (Figure 14E&F). We also observed blebbing of the cell
membrane on some cells (Figure 14E, arrow head), which would support an increase in
apoptosis by AMs, but we were unsure if this was a result of cytocentrifugation and did
not count these cells. Quantification of the percent of phagocytic macrophages showed
20% of AMs from intoxicated and injured mice are in the process of efferocytosis,
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Figure 14. Increased percent of phagocytic alveolar macrophages after intoxication and
injury. BAL cells were cytocentrifuged onto slides and stained with a HEMA 3
differential stain. Images demonstrate the predominance of alveolar macrophages in BAL
from A) sham vehicle and B) burn ethanol treatment groups. Arrows indicate active
alveolar macrophages in the process of efferocytosis after intoxication and injury. 400x
magnification. Higher magnification of BAL cells in C) sham vehicle, and D-F) burn
ethanol in various stages of phagocytic activity. We postulated these stages were D)
macropinocytosis E) early stage of engulfment and F) later stage of engulfment. Arrows
indicate active alveolar macrophages in the process of efferocytosis after intoxication and
injury and arrow head indicates cell with blebbing membrane. 1000x magnification. G)
Quantification of the percent of phagocytic cells per 400x field. Active-caspase-3 (red)
and dapi (blue) staining of BAL cells was assessed using fluorescent microscopy H) with
differential interference contrast (DIC) and I) without DIC. The DIC channel outlines a
caspase-3+ cell engulfed by another cell. *p< 0.05. By unpaired T-test. Data are shown as
mean ± SEM. N= 3-4 animals per group.
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a 5-fold increase comparison to sham mice (p<0.05) (Figure 14G). We predicted the
larger bodies within AMs were apoptotic cells and confirmed this using antibody against
active-caspase-3 (Figure 14H-I). This was further supported by our findings in situ of
Siglec-F+ AMs interacting with small cells with minute nuclei, potentially indicative of
dead cells (Figure 15A&B).
Cytokine production by AMs
To determine cytokine production by AMs after intoxication and injury,
supernatant was collected from cultured AMs from both sham and intoxicated and injured
mice. Results demonstrated that without additional stimulation, AMs from intoxicated
and injured mice spontaneously produce 5-fold more TNFα than sham animals (p<0.05)
(Figure 16). Other cytokines, such as IL-6, KC, IL-1β, MCP-1 and IL-10 were not
present in the supernatant. These data suggest AMs are not a main source of the IL-6 and
KC found in the lungs of mice subjected to intoxication and injury. Furthermore,
cytokine analysis of BAL fluid did not show significant changes in KC, MCP-1 or GMCSF (Figure 17). While it was not significant, intoxicated and injured mice did have an
approximate 3-fold increase in the average amount of IL-6, in comparison to sham mice
(Figure 17A). These data, taken together with cultured AM cytokine analysis, could
imply airway cells are a source of elevated lung IL-6. No change in KC in the airways is
not surprising considering neutrophil infiltration is into the interstitium and not into the
alveolar space, suggesting other cells, such as endothelial cells may be a source of lung
KC.
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Figure 15. In vivo efferocytosis by Siglec-F+ AMs in lung tissue after intoxication and
injury. Lung tissue from intoxicated and burn injured-mice was stained for Siglec-F+
(red) and assessed for AMs efferocytosis of other cells. Representative image of SiglecF+ AM in close proximity to small, nucleated cell is shown at A) 400x and B) 1000x.
White arrows point to small, nucleated cell.
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Figure 16. Elevated AM production of TNFα. AMs were cultured for 1.5 h at 37°C and
supernatant was removed and assessed for cytokines by multi-plex bead array. Data
represented as picograms per milliter. * p < 0.05. By unpaired T-test. Data are presented
as mean ± SEM. N = 3-6 animals per group.
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Figure 17. BAL fluid cytokine and chemokine levels. Lungs were lavaged 5x with 1mL
PBS and BAL fluid was analyzed for A) IL-6, B) KC, C) MCP-1 and D) GM-CSF. Data
represented as picograms per milliter. Not significant by unpaired T-test. Data are
presented as mean ± SEM. N = 3-4 animals per group.
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Neutrophil numbers in the lung after clodronate depletion of AMs
The role of AMs in pulmonary inflammation after intoxication and injury was
further investigated by locally depleting AMs using clodronate liposomes in both sham
and intoxicated and injured animals. Clodronate or empty liposomes were administered
i.t. 3 days prior to injury. Clodronate liposomes specifically reduced CD11c+CD11bSiglec-F+ AMs from the lungs in both sham and injured mice at 24 h after injury, in
comparison to empty liposome treated mice (p<0.05) (Figure 18A&B). Examination of
lung tissue sections revealed that intoxicated and injured mice treated with clodronate
liposome had 2-fold more neutrophils, in comparison to intoxication, injury and empty
liposome treated mice (Figure 19C-E). This increase was not seen in sham mice given
empty or clodronate liposomes (Figure 19A&B). Flow cytometry analysis further
supports these data showing a 1.5-fold increase in CD11b+Ly-6G+ neutrophils in the
lungs of intoxicated, injured, and clodronate treated mice, in comparison to those of
empty liposome treated mice (Figure 19F). This elevation in neutrophil numbers
significantly correlated to a decrease in AM numbers in intoxicated and injured mice
treated with clodronate liposome, relative to that of intoxicated injured mice given empty
liposome (r = -0.8983) (Figure 19G). Interestingly, we did not observe significant
changes in lung tissue levels of KC after the depletion of AMs (Figure 19H). This further
supports the importance of other cells types, such as endothelial cells, as a major source
of this neutrophil chemokine. Serum levels of IL-6 were also not altered by the depletion
of AMs (Figure 19I).
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Figure 18. Clodronate liposome treatment depletes AMs. Lung tissue was obtained 24 h
post-injury from all treatment groups. Tissue was enzymatically dissociated into a single
cell suspension and cells were analyzed by flow cytometry. A) Representative gating for
Siglec-F+AMs of CD11c+CD11b- cells (data not shown) from all four treatment groups.
B) Absolute number of AMs in lung isolates. *p < 0.05 versus all groups, by One-way
ANOVA. # p < 0.05 versus burn ethanol + clodronate liposome, by unpaired T-test. Data
are presented as mean of number of AMs per 350,000 lung cells ± SEM. N = 3-6 animals
per group.
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Figure 19. Assessment of pulmonary inflammation in AM depleted, intoxicated and burninjured mice. A-D) Lungs were sectioned and stained with H&E and assessed for
cellular infiltration. Representative sections from each treatment group are shown at
1000x. E) Neutrophils were counted by light microscopy in H&E-stained lung sections
24 h after intoxication and burn injury. Data are shown as the total number of neutrophils
in 5 high power fields (400x). Not statistically significant. F) Flow cytometric analysis of
dissociated lung tissue Ly-6G+CD11b+ neutrophils. Data representative as absolute
number of neutrophils per 350,000 cells. G) Pearson correlation of AM cell counts to
neutrophil cell counts from the lungs of intoxicated and burn injury mice, with or without
clodronate treatment , r = -0.8983. H) Lung homogenates from all four treatment groups
were analyzed for levels of KC. I) Serum from all four treatment groups were analyzed
for IL-6. *p <0.05 versus sham vehicle + empty liposome. Data are presented as mean ±
SEM. N = 3-6 animals per group.
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We have established there is a significant correlation between neutrophil infiltration
and decreased lung function [156]. In these studies we show that there is also a
significant correlation between the loss of alveolar macrophages and heightened
neutrophil numbers in lung tissue. We predicted that depletion of AMs with clodronate
liposomes prior to intoxication and injury would further impair lung function. In
contrast, there was no significant difference in Penh, breath frequency, tidal volume, or
minute volume (Figure 20), in comparison to injured mice treated with empty liposomes.
Our recent observations of lung function in intoxicated and injured mice were from
studies in which a multi-day episodic binge ethanol exposure regimen was utilized.
Repeated exposure to ethanol before injury may result in greater lung impairment than a
single dose of ethanol exposure. Moreover, in this experiment, numbers of AMs were
drastically reduced by 75% after just intoxication, injury and empty liposome treatment,
in comparison to sham mice given empty liposome. The additional loss of a small
percentage of remaining AMs after clodronate liposome treatment therefore may not
result in greater lung impairment.
Finally, we analyzed lung tissue for TUNEL+ cells. We discovered that clodronate
treatment alone, 3 days after it was administered, resulted in remnants of apoptotic cells,
in comparison to empty liposome treated mice (Figure 21A&B). Consistent with our
previous observations (Figure 21C&E), intoxicated and burn injured mice given empty
liposomes had more TUNEL+ cells, in comparison to empty liposome treated sham mice.
Unfortunately, treatment of sham or intoxicated and injured animals with clodronate
liposomes yielded TUNEL+ debris throughout the lung tissue (Figure 21 D&F),
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Figure 20. Clodronate liposome depletion of AMs does not increase lung impairment.
Mice were placed in an unrestrained whole body barometric plethysmography chamber
and lung function parameters were recorded for 10 minutes. A) Penh, B) Breath
frequency, C) Tidal volume and D) Minute volume. Data points shown as individual
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Figure 21. Clodronate liposome increases apoptotic debris in lung tissue. An
immunofluorescent in situ TUNEL assay was used to identify apoptotic cells in lung
tissue. Representative images of TUNEL+ cells (green) in each treatment group. Left
panel, control liposome treated A) unmanipulated C) sham vehicle and E) burn ethanol.
Right panel, clodronate liposome treated B) unmanipulated D) sham vehicle and F) burn
ethanol. 200x magnification.
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Highlighting a limitation of clodronate liposome depletion of AMs to study apoptosis.
In intoxicated and injured mice treated with clodronate liposome, lung tissue had both
TUNEL+ debris and punctate cells, further suggesting that the increase in apoptotic cells
is not representative of only AM apoptosis but also of other lung cell types (Figure 21F).
Summary
Higher SSC granularity, altered expression of TLR4/MD-2, and increased
production of TNFα together suggest AMs from intoxicated and injured mice have an
activated, pro-inflammatory phenotype. The elevated secretion of TNFα and the
increased surface expression of MARCO and CD11b on AMs, both important receptors
in phagocytosis and efferocytosis, coincide with elevated numbers of apoptotic cells in
lung tissue after injury. Furthermore, morphological analysis revealed a percentage of
AMs from intoxicated and injured mice could effectively take up apoptotic cells. We
determined AMs are a small population of these apoptotic cells, but the majority of
apoptotic cells are likely epithelial or endothelial cells.
The literature suggests that efferocytosis by AMs initiates the transition from an
inflammatory phase towards a resolution phase. Our data revealed there is a 50%
reduction in the total number of AMs and, of the AMs that were present, less than 20%
were active in efferocytosis. Minimal AM efferocytosis in the presence of elevated
numbers of apoptotic cells consequently can hinder the process of transitioning to a
resolution phase. Clodronate experiments confirmed AMs also have a role in limiting
neutrophil numbers into the lungs after intoxication and injury. The negative correlation
between decreased AM numbers and increased neutrophil numbers proposes elevated
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neutrophil infiltration after intoxication and injury is a result of AM deficiency in the
lung tissue. We speculate lack of mediators released in response to efferocytosis by AMs
(i.e. IL-10 or TGFβ) is responsible for the increase in neutrophil accumulation. Overall,
our data demonstrate that both the loss of AMs and a heightened pro-inflammatory
profile on remaining AMs, may prolong pulmonary inflammation after intoxication and
injury, underlining a mechanism for impaired lung function and increased incidences of
mortality.

CHAPTER 5
MESENCHYMAL STEM CELLS ATTENUATE PULMONARY INFLAMMATION
AFTER INTOXICATION AND BURN INJURY
Abstract
Clinical evidence reveals that 50% of burn patients are under the influence of alcohol at
the time of hospital admission and that the combined insult of alcohol and burn injury
causes increased risk of pulmonary complications leading to multiple organ failure and
death. Our previous work demonstrated that a mouse model of alcohol and burn injury
resulted in prolonged pulmonary inflammation characterized by amplified neutrophil
accumulation and dramatic increases in pro-inflammatory cytokines and chemokines
relative to burn injury and sham groups. Recent studies indicated the role of AMs in
amplifying pulmonary inflammation after intoxication and injury. Mesenchymal stem
cells (MSCs) have been shown to attenuate acute lung inflammation, specifically by their
ability to modulate the phenotype of AMs. Therefore, we explored exogenous MSCs as a
post-injury therapy in a mouse model of intoxication and burn injury. Eight week-old
C57BL/6 male mice were subjected to binge alcohol exposure Thirty minutes following
the final ethanol exposure, mice were given a 15% total body surface area dorsal scald
injury. One hour after injury, intoxicated and burn-injured mice were given an
intravenous injection of CFSE labeled bone marrow-derived MSCs (5x105 i.v.). We
detected a small percentage of CFSE+ MSCs in the lungs at 24 h post injury and assessed
80
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lung tissue for pulmonary inflammation. We found that intoxicated and injured mice
treated with MSCs had a decrease in infiltrating neutrophils into the lungs that paralleled
reduced neutrophil chemoattractant KC (CXCL1) and pro-inflammatory IL-6 levels in
lung tissue. Our data suggest that one way in which MSCs attenuated pulmonary
inflammation is by the activation of anti-inflammatory AMs. Together, these data
demonstrate that exogenous administration of MSC to mice after intoxication and burn
injury reduced pulmonary inflammation, highlighting MSCs as therapeutic targets that
can improve survival in all burn patients.
Introduction
Binge drinking is an increasingly prevalent activity in the United States and is the
most common form of alcohol consumption [61]. It is defined by a blood alcohol
concentration of 0.08% or by the number of alcoholic drinks an individual has with in a 2
hour time period (4 for women, 5 for men), and is the most common drinking pattern
among patients with traumatic injury, including burn injury [66, 87]. Clinical evidence
reveals that half of the burn patient population is under the influence of alcohol at the
time of injury [88, 89]. This combined insult results in greater fluid resuscitation, a
longer hospital stay and an increase in the number of days spent on mechanical
ventilation, leading to a greater risk pulmonary complications and mortality [89, 92, 168].
Our laboratory and others have used a murine model of ethanol intoxication followed by
a moderate size burn injury to study how intoxication exacerbates inflammation in
various organ systems, including the lungs. With this combined insult, the lungs display
characteristics of acute respiratory distress syndrome, including elevated levels of
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alveolar wall thickening, neutrophil accumulation and increased pro-inflammatory
cytokine interleukin-6 (IL-6) levels, relative to either ethanol exposure or burn injury
alone [99, 104-107]. This amplification of pulmonary inflammation has also been
correlated to a decrease in physiological lung function and an increase in mortality [156].
The lungs are often the first organs to fail after traumatic injury [84], hence, managing
the excessive inflammatory response seen after remote injury will likely reduce elevated
morbidity and mortality in intoxicated and burn-injured patients.
Resident alveolar macrophages play a critical role in both the onset and resolution
of pulmonary inflammation [157, 162, 169]. The activation of tissue resident
macrophages by endogenous danger signals or by the detection of pathogens through
pattern recognition receptors stimulate macrophages to release pro-inflammatory
cytokines that initiate the inflammatory process, such interleukin-1β, tumor necrosis
factor α (TNFα), and interferon-γ [157]. During the course of inflammation, the up
regulation of anti-inflammatory mediators or the phagocytosis of apoptotic cells by
macrophages, activate macrophages into an alternative M2, anti-inflammatory phenotype,
facilitating the resolution of inflammation [51, 52, 170]. Alveolar macrophages are the
first line of defense against inhaled particles or pathogens. This environment, with a
direct connection to open-air, leads to a distinct phenotype with atypical macrophage cell
surface markers, in comparison to other macrophage populations. Alveolar macrophages
can be characterized by dendritic cell marker CD11c and eosinophil marker Siglec-F, but
are negative for classical macrophage marker CD11b [20, 21, 158]. Additionally, the
constant exposure to inhaled or blood-born pathogens results in alveolar macrophages
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constitutively expressing mannose receptor CD206 [21, 169], an important receptor that
assists in the clearance of foreign antigens [171]. CD206 has also been characterized as a
marker of alternative macrophage activation [34, 162-164]. Thus, an upregulation of
CD206 on alveolar macrophages from baseline line levels may suggest a transition to an
M2 phenotype. With the excessive pulmonary inflammation observed after intoxication
and injury, triggering the anti-inflammatory, resolving and/or reparative macrophage
phenotype could be critical to restoring lung homeostasis.
Bone marrow and tissue resident mesenchymal stem cells (MSCs) have been
characterized as modulators of acute inflammation by virtue of their ability to influence
the phenotype of macrophages [119]. Exogenous MSC interaction with macrophages and
their release of paracrine soluble factors have been shown to suppress inflammation and
polarize macrophages into an alternative, anti-inflammatory phenotype [119-123].
Notably, experimental studies using murine models of allergic asthma demonstrated the
localized benefits of MSC treatment in the lungs. In one murine study, short-term
localization of exogenous human MSCs (hMSCs) within the lungs was sufficient to
inhibit allergic inflammation. Through clodronate liposome depletion of alveolar
macrophages, this study established that the anti-inflammatory effect of MSCs was
dependent on alveolar macrophages and their indirect role in the upregulation of IL-10
[172]. Recent reports additionally showed hMSCs can reduce allergic inflammation and
improve lung function through TGFβ signaling and the upregulation of M2 alveolar
macrophages, [173]. Additionally, incubating the RAW264.7 macrophage cells line with
MSC conditioned medium has been shown to induce the expression of the M2 marker
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CD206 in [174]. Moreover, many studies also suggest the intravenous administration
of MSCs results in the entrapment of MSCs within the lungs. Due to their large size,
MSCs becomes trapped within the pulmonary vasculature with only a fraction of these
cells passing through and migrating to other organs [124-126]. The resulting reduction in
capillary flow allows MSCs to secrete anti-inflammatory mediators specifically into the
lung niche, reducing inflammation [175]. This limitation of MSC therapy, combined
with the ability of MSCs to attenuate inflammation through the anti-inflammatory
polarization of macrophages, suggests MSCs would be particularly advantageous to
attenuating elevated lung inflammation after intoxication and injury.
The purpose of this study was to determine whether the intravenous infusion of
exogenous bone marrow-derived MSCs will reduce pulmonary inflammation after
intoxication and burn injury and if this parallels a shift in alveolar macrophage
phenotype. Since intoxication at the time of injury results in greater pulmonary
complications and mortality rates than burn injury alone, we examined the effect of MSC
treatment on only intoxicated and burn-injured mice, in comparison to sham vehicle
control. In vitro-expanded MSCs were given intravenously to intoxicated and burninjured mice 1 hour after injury. Pulmonary inflammation was assessed by neutrophil
infiltration, neutrophil chemokine CXCL1 (KC) and IL-6 levels in lung tissue, while
alveolar macrophage phenotype was analyzed by flow cytometry. Our results suggest
MSCs can reduce pulmonary inflammation, possibly by polarizing alveolar macrophage
to an anti-inflammatory phenotype, highlighting MSCs as a novel therapeutic agent to
treat lung-specific inflammation in severe burn patients.
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Materials & Methods
Mice
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor,
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under
specific pathogen-free conditions in the Loyola University Medical Center Comparative
Medicine facility. All experiments were conducted in accordance with the Institutional
Animal Care and Use Committee. Mice weighing between 22 to 27 g were used in these
studies.
Mesenchymal Stem Cell Culture
Gibco® Mouse (C57BL/6) bone marrow (BM)-derived MSCs (Life Technologies, Grand
Island, NY) were expanded in vitro per manufacturer protocol. Briefly, MSC growth
medium consisted of 10% FBS and 10mg/ml genatmicin in MEMα Medium with
GlutaMAX™-I, ribonucleosides and deoxyribonucleosides. MSCs were plated at a
density of 5,000 cells per cm2 in T75 flasks and incubated at 37oC, 5% CO2 and 90%
humidity. Medium was changed every 2 days until cultures were 70-80% confluent.
MSCs were detached from flasks using pre-warmed trypsin, fluorescently labeled with
carboxyfluoresceindiacetate, succinimidyl ester (CFSE), following manufacturer protocol
(Life Technologies) and resuspended in sterile Dulbecco’s phosphate buffered saline
(PBS) [176]. Additionally, MSCs were analyzed by flow cytometry for MSC markers.
Briefly, MSCs were incubated with anti-mouse antibodies C-kit APC-eFluor 780 (clone
ACK2, eBioscience), CD31PE (clone 390, eBioscience), Sca-1 PerCP Cy5.5 (clone D7,
eBioscience), CD34 eFluor 660 (clone RAM34, eBioscience), and CD44 PE-Cy7 (clone
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IM7, eBioscience). Antibody incubation was carried out for 30 minutes at 4 C. Cells
were washed and fixed as described [143, 153]. Data analysis was performed using Flow
Jo FCS analysis software (Tree Star Inc., Ashland, OR). Passage 3 cells were used in all
experiments.
Murine Model of Binge Ethanol and Burn Injury
A murine model of single dose binge ethanol intoxication and burn injury was
employed using oral gavage as described previously [138, 150, 151]. Animals were given
400 μl of 10% (v/v) ethanol solution (1.6 g/kg) or water control by gavage at a dose
designed to elevate the blood alcohol concentration to 150 mg/dL at 30 min after ethanol
exposure [142]. Thirty minutes following the ethanol exposure, the mice were
anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine) and their dorsums shaved. The
mice were placed in a plastic template exposing 15% of the total body surface area and
subjected to a scald injury in a 92-95°C water bath or a sham injury in room-temperature
water [138]. The scald injury results in an insensate, full-thickness burn [152]. The mice
were then resuscitated with 1.0 ml saline and allowed to recover on warming pads. All
experiments were performed between 8 and 9 am to avoid confounding factors related to
circadian rhythms. One hour after injury, intoxicated and burn-injured animals either
received an intravenous tail vein injection of 5x105 CFSE-labeled MSCs or PBS as a
control in 200ul [124]. Animals were euthanized at 24 hours.
Histopathologic Examination of the Lungs
The upper right lobe of the lung was inflated with 10% formalin and fixed
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and
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stained with hematoxylin and eosin (H&E). Sections were evaluated using light
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were
taken at 400x magnification. Neutrophils were counted in a blinded fashion in 10 high
power fields (400X). The upper left lobe was inflated with 25% OCT freezing medium,
frozen in OCT over dry ice and store at -80oC. Tissue was cryosectioned at 6 μm and
assessed for CFSE fluorescent MSCs.
Cytokine Analysis of Lung Homogenates
The right middle lung lobe was snap-frozen in liquid nitrogen and then
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine
production using a BioPlex multiplex bead array. The results were normalized to total
protein using the BioRad protein assay (BioRad) [106, 107].
Flow Cytometry Analysis of Alveolar Macrophages
The upper left lung lobe was removed and cut into small pieces with a razor
blade. The lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA)
and processed using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml
DNase I (Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi
Biotec), according to manufacturer’s instructions (Shults et al. 2015). The homogenates
were then filtered through 70 um nylon cell strainers to obtain a single cell suspension.
Red blood cells were lysed using ACK lysis buffer (Life Technologies, Grand Island,
NY). Cells were counted using trypan blue to exclude dead cells. To assess alveolar
macrophages, 1x106 lung cells were first incubated with anti-CD16/32 (clone
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93,eBioscience, San Diego, CA) to block unspecific binding to the Fcy II/III receptor.
Cells were then immunostained with rat anti-mouse antibodies: F4/80 APC (clone BM8,
eBioscience), CD11b eFluor 450 (clone M1/70, eBioscience), Siglec-F PE-CF594 (clone
E50-2440, BD Biosciences, San Jose, CA), CD206 PE (clone C068C2, Biolegend, San
Diego, CA). CFSE+ cells were identified using a FITC channel. Antibody incubation was
carried out for 30 minutes at 4oC. Cells were washed and fixed as described [143, 153].
MHC II was used as a M1 marker and CD206 was used a M2 marker [21]. Samples were
run on a BD Fortessa cytometer (BD Biosciences). Data analysis was performed using
Flow Jo FCS analysis software (Tree Star Inc.).
Serum Measurements
Blood was collected via cardiac puncture and the serum was isolated at stored at -80°C.
Serum aliquots were used to measure IL-6 by enzyme linked immunosorbent assay
(ELISA) (BD Biosciences, Franklin Lakes, NJ) or liver alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) levels using a DRI-CHEM 7000 (HESKA,
Loveland, CO).
TUNEL Immunofluorescent Staining
The upper right lobe of the lung was inflated with 10% formalin and fixed overnight as
described previously [104], embedded in paraffin, sectioned at 5 μm. An in situ TUNEL
assay was performed according to manufacturer’s protocol (Life Technologies). Sections
were evaluated using fluorescent microscopy (EVOS, Life Technologies) and TUNEL+
were counted in a blinded fashion in 10 low power fields (100X).
Statistical Analysis
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Statistical comparisons were made between the sham vehicle, burn ethanol +
PBS, and burn ethanol + MSC treatment groups. One-way analysis of variance
(ANOVA) was used with Tukey’s post-hoc test and values were considered statistically
significant when p < 0.05. Data is reported as mean values ± the standard error of the
mean (SEM).
Results
Mesenchymal stem Cells are Present the Lungs 24 h after Administration
Gibco® Mouse (C57BL/6) BM-derived MSCs were purchased from Life
Technologies. These cells were described to have tri-potential differentiation into at least
osteogenic, adipogenic, and chondogenic lineages, as well as express a flow cytometry
phenotype of Sca-1+CD34+CD44+CD29+c-kit-, which is characteristic of BM-derived
MSCs. To confirm the phenotype of these MSCs, we analyzed confluent MSCs (passage
3) using flow cytometry (Figure 22). We found the MSCs were Sca1+CD34+CD44+CD29+, negative for CD31, and had less than 5% positive for c-kit
(Figure 22A-F). Additionally, in adoptive transfer experiments, MSCs were labeled with
CFSE (Figure 23A) and administered to mice an hour after burn injury. At 24 h, CFSE+
MSCs were identified in the lungs of intoxicated and burn injured mice using flow
cytometry (Figures 23B&C). Lung cells were negatively selected for alveolar
macrophage/eosinophil marker Siglec-F and granulocyte/neutrophil marker CD11b (data
not shown), and analyzed for CFSE+ cells compared to macrophage/monocyte marker
F4/80 (Figure 1). Additionally, CFSE+ cells were negative for dendritic cell marker
CD11c (data not shown). Our results indicated there were approximately 100 CFSE+
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Figure 22. Flow cytometry analysis of MSCs confirms phenotype. A) Representative
gating (Blue) for MSCs. B-G) MSCs (red) expression was compared against controls
(blue) for B) c-kit, C) CD31, D) Sca-1, E) CD34 and F) CD44. G) Immunofluorescent
staining confirming CD29 expression, in comparison to a Rat IgG2a control antibody.
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Figure 23. MSCs localize in lung tissue. CFSE+ MSCs were identified in dissociated
lung tissue from intoxicated and injured mice at 24 h using flow cytometry.
A) Confirmation of MSCs fluorescence prior to tail vein injection. B&C) Total
dissociated lung cells were negatively selected for Siglec-F and CD11b (data not shown),
followed by the identification of F4/80- CFSE+ cells (box) in B) burn ethanol + PBS and
C) ethanol + MSCs.
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MSCs recovered per 3.5 x 10 total lung cells. Lack of Siglec-F, CD11b, F4/80 and
CD11c expression supports the identification of individual CFSE+ cells and not CFSE+
cells engulfed by macrophage/monocytes, granulocytes, or dendritic cells. These data
confirm that MSCs are in a position to attenuate pulmonary inflammation by their ability
to localize in the lungs and remain there at least 24 h after infusion.
MSC Treatment Reduces Pulmonary Inflammation after Intoxication and Burn Injury
As previously shown by our laboratory, histochemical analyses of sectioned lung
tissue demonstrated that ethanol intoxication prior to burn injury results in a 1.5 fold
increase in cellularity, primarily by neutrophils, in comparison to burn injury alone at 24
hours after injury [104-107, 156]. Administration of MSCs 1 hour after injury decreased
cellular infiltration and reduced pulmonary congestion after intoxication and injury
(Figure 24A). Neutrophils within the lung interstitium were counted by light microscopy
as previously described [104]. The increase in neutrophil infiltration into the lungs after
intoxication and injury was attenuated with MSCs treatment and overall reduced
neutrophil infiltration by 33% (Figure 24B). Additionally, the lung, liver, and skin
(approximate to wound interface) were assessed for the presence of CFSE+ MSCs. At 24
h after injury we were unable to identify CFSE+ cells in either tissue using
immunofluorescence. However, we were able to identify CSFE+ cells in the lung using
flow cytometry. Analysis of lung tissue indicated an average of 100 CFSE+ MSCs per
350,000 total cells (~0.3%) (Figure 23C) remained in the lung at 24 h. Supporting these
data, Eggenhofer and colleagues found the majority of viable MSCs were within the
lungs at 1 h and at 24 h, their presence in the lungs was significantly reduced [124].
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Figure 24. Histological assessment of pulmonary inflammation. Lungs were sectioned
and stained with H&E and assessed for cellular infiltration. A) Representative sections
from each treatment group are shown at 400x. B) Neutrophils were counted by light
microscopy in H&E-stained lung sections 24 h after intoxication, injury and MSC
treatment. Data are shown as the total number of neutrophils in 5 high power fields
(400x). Not significant. Data are presented as mean values ± SEM. N = 3-4 animals per
group. Representative of 2 independent experiments.
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Decreased Pulmonary KC and Interleukin-6 (IL-6) Levels
Since we observed decreased neutrophil infiltration with MSC treatment, we next
examined pulmonary neutrophil chemoattractant, KC and pro-inflammatory cytokine IL6 levels. Consistent with previous studies, there was an 11-fold increase in KC (p < 0.05)
in lung tissue, of intoxicated mice subjected to burn injury in comparison to control
animals (Figure 25A) [104-106, 156] .This paralleled a 5.6 fold increase in IL-6 levels (p
< 0.05) (Figure 25B). MSC treatment reduced KC levels by a 50% and IL-6 levels by
70% (Figure 25A&B). These data support our observation that MSC treatment decreases
neutrophil infiltration into lung tissue, overall reducing pulmonary congestion.
Surprisingly, we found no difference in the level of the anti-inflammatory interleukin-10
(IL-10) between experimental groups, even after MSC treatment and reductions in IL-6
(data not shown).
Serum IL-6 Attenuated with Mesenchymal Stem Cells
Dramatic increases in circulating IL-6 levels have been detected with intoxication
and injury, relative to either insult alone [139] and a high serum level of IL-6 in burn
injured patients has been correlated with increased chance of morbidity and mortality
[101]. Here, we also found that intoxication and burn injury significantly upregulates
serum levels of this cytokine (p < 0.05) and found that treating intoxicated and burninjured animals with MSCs reduced serum IL-6 by 50% (Figure 26). The liver is likely
one of the primary sources of IL-6 after intoxication and injury. We, therefore, analyzed
levels of liver IL-6, as well as markers of hepatic damage, liver aminotransferases AST
and ALT. Consistent with previously data [99, 177], intoxication and burn injury
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Figure 25. MSCs attenuate pulmonary KC and IL-6 levels. Lung homogenates were
analyzed for levels of A) KC and B) IL-6. * p < 0.05 versus sham vehicle; # p < 0.05
versus all groups. By One-way ANOVA. Data are presented as fold-change ± SEM. N =
3-4 animals per group. Representative of 2 independent experiments.
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Figure 26. MSCs reduce serum levels of pro-inflammatory IL-6. Serum was collected
from each treatment group and analyzed for IL-6. Not significant. Data are presented as
the mean in picograms per milliter ± SEM. N = 3-6 animals per group.
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Table 2: MSCs do not alter liver cytokine and serum aminotransferase levels.

Liver homogenates were analyzed for levels of IL-6. IL-6 is presented as the mean in
picograms per milliter ± SEM. Serum was collected from each treatment group and
analyzed for AST and ALT. AST and ALT are presented as the mean units per liter ±
SEM. * p < 0.05 versus sham vehicle. N = 3-6 animals per group.
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elevated hepatic levels of IL-6 (p < 0.05), ALT (p < 0.05), and AST (p < 0.05), relative
to control animals. While MSC treatment restored pulmonary parameters, it failed to
diminish the levels of these factors in the liver (Table 2). Since MSC treatment
significantly reducing both lung IL-6 and systemic IL-6, but not liver IL-6, this suggests
that the MSCs have a direct effect on lung tissue. Additionally, these data propose that
the liver is not the only source of systemic IL-6 after intoxication and burn injury and that
the lungs may also contribute to systemic levels.
Elevated CD206hi Alveolar Macrophages 24 hours
after Mesenchymal Stem Cell Treatment
We have shown that the administration of MSCs to intoxicated and injured
animals reduces inflammation in the lungs, but not on the liver. We postulated this may
be due to MSC activation of alveolar macrophages towards an anti-inflammatory
phenotype [121, 172, 173]. Therefore, we next analyzed alveolar macrophages by flow
cytometry for M1 and M2 markers, MHC II and CD206, respectively. Lung tissue was
digested into a single cell suspension and stained for alveolar macrophage cell surface
markers. As shown in Chapter 4, Siglec-F+CD11c+CD11b- alveolar macrophages have
low to negative levels of MHC II and constitutive expression of CD206 (Figure 27B)
[21]. To determine if MSCs altered the phenotype of alveolar macrophages in
intoxicated and burn-injured animals we analyzed alveolar macrophages after
intoxication, injury and MSC treatment and observed an increase in a population of
alveolar macrophages with heightened expression of CD206 (Figure 27A-C). We
quantified the percent of CD206hi alveolar macrophages out of total alveolar
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Figure 27. CD206hi AMs are upregulated after MSCs treatment. Lung tissue was
dissociated into a single cell suspension and cells were analyzed by flow cytometry. A-C)
Representative gating for CD11c+CD11b-Siglec-F+CD206hi alveolar macrophages (box)
from each treatment group. D) Percentage of CD206hi cells of total alveolar
macrophages. E) Scatterplot representation of mean fluorescence intensity (MFI) of
MHC II on alveolar macrophages from each treatment group. * p < 0.05 versus all
groups. By One-way ANOVA. Data are presented percentage CD206hi cells per group ±
SEM. N = 3-5 animals per group.
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macrophages and found a 1.5-fold increase (p < 0.05) in these cells after intoxication,
injury and MSC treatment, in comparison to intoxication and injury alone (Figure 27D).
However, we found no change in the level of MHC II expression between all treatment
groups at 24 h (Figure 27E). This was not surprising considering pulmonary
inflammation after intoxication and injury likely mirrors sterile inflammation where we
would not expect antigen presentation. These findings suggest MSCs may diminish
pulmonary inflammation through the direct or indirect activation of alveolar macrophages
into an M2 phenotype, overall highlighting MSCs as a viable therapy to locally suppress
pulmonary inflammation in intoxicated and burn-injured patients.
Decreased Apoptosis in Lung Tissue
The average number of TUNEL+ apoptotic cells in lung tissue was quantified after
intoxication, injury and MSCs. We found a 33% decrease in the number of TUNEL+
cells with MSC treatment, however, mice treated with MSCs still had a 4.5-fold increase
in apoptotic cells in comparison to sham (Figure 28A). We also found no difference in
the number of alveolar macrophages after MSC treatment (Figure 28B). This suggests
that the reduction in pulmonary inflammation as a result of MSC infusion may attenuate
the cell death of a portion of lung cells, such epithelial or endothelial cells, but not
alveolar macrophages. The studies herein did not determine how early after injury there is
a decrease in the alveolar macrophage population, but the literature has shown apoptosis
in the lungs as early as 3 h after burn alone in rats [116]. One study also demonstrated the
majority of MSCs are within the lungs at 1 h after administration [124], therefore if we
inject MSCs 1 h after injury, the majority of MSCs are in the lungs at 2 h after injury and
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apoptosis in the lungs after intoxication and injury may have already been initiated by
this time point.
Summary
The above studies demonstrate that the intravenous administration of exogenous MSCs
have the ability to reduce both lung and systemic IL-6, a cytokine that has been described
to play a causative role in the excessive pulmonary inflammation after intoxication and
injury [107]. To this end, neutrophil chemokine KC levels and neutrophil infiltration into
the lungs were also reduced after MSC treatment. Whether this was a direct outcome of
decreased IL-6 levels was not determined in this study. Additionally, the entrapment of
MSCs within the lung capillary bed may have led to the activation of alveolar
macrophages into an anti-inflammatory phenotype resulting in a decrease in both
systemic IL-6 and pulmonary inflammation, identifying the lungs one source of this proinflammatory cytokine. Taken together, these data suggest that the anti-inflammatory
properties of MSCs, through either the direct or indirect interaction with resident alveolar
macrophages may be helpful in initiating the resolution of pulmonary inflammation and
either decreasing apoptosis or stimulating efferocytosis to remove apoptotic cells after
intoxication and injury. These studies highlight MSCs as a useful therapeutic to
specifically target lung inflammation. More studies are warranted to determine their
effectiveness in a clinical application in the context of systemic inflammation.
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Figure 28. Decreased apoptotic cells in the lung after intoxication, injury and MSC
treatment. An immunofluorescent in situ TUNEL assay was used to identify apoptotic
cells in lung tissue. A) Average number of apoptotic cells per 10x field. Not Significant.
B) Average number AMs per 350,000 lung cells. Not Significant. Data are shown as
mean ± SEM. N=3-4 animals per group.

CHAPTER 6
DISCUSSION
In review, clinical studies indicate patients who are intoxicated at the time of burn
injury have an increased risk of pulmonary complications and failure. Previous studies in
our laboratory described elevated levels of neutrophils, neutrophil chemokines, KC and
MIP-2, and IL-6 within lung tissue of intoxicated and burn-injured mice, relative to either
insult alone. However, it had not been determined what underlying mechanism in the
lung caused these changes or if they affected physiological lung function. With the
knowledge that AMs are key orchestrators of both the initiation and resolution of
inflammation, we hypothesized elevated pulmonary inflammation was a result of
alterations in the AM population. To study the role of AMs in pulmonary inflammation
and the effect of inflammation on lung function after intoxication and injury, we used a
mouse model of binge ethanol exposure and scald injury. The results described in this
dissertation correlate heightened pulmonary inflammation with impaired lung function
and identify AMs as important regulators of both inflammation and targets of therapeutic
interventions.
Lung inflammation can cause physiological derangements in intoxicated and
burn-injured animals, including increased airway resistance and abnormal breathing
patterns. Non-invasive, unrestrained whole-body plethysmography is a convenient
method to evaluate normal breathing patterns in mice [178]. Unlike invasive
103
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methods using a tracheotomy and mechanical ventilation to study plethysmography,
non-invasive techniques do not require anesthesia or surgery. This significantly reduces
stress and allows individual animals to be assessed multiple times, a useful feature for
time course studies [178-180]. In non-invasive plethysmography, Penh is a
dimensionless parameter that has been viewed as a measure of bronchoconstriction and
airway resistance, though several studies claim Penh is an unreliable measure of
respiratory mechanics [181, 182]. However, other studies suggest Penh should be used as
a measure of overall lung function, highlighting changes in respiratory breathing patterns
[178, 183, 184]. Verheijden, et. al. recently compared non-invasive plethysmography
(Penh) to invasive plethysmography (Resistance) in a severe model of allergic airway
inflammation. Their data revealed an increase in both Penh and resistance with severe
allergic airway inflammation. Notably, a Penh of 8 corresponded to a significant increase
in resistance, compared to controls, suggesting that in severe models of inflammation,
Penh is a reflective measure of resistance. Additionally, it was determined an increase in
Penh paralleled an increase in bronchoalveolar lavage cells in the airways [183],
furthering supporting our data that pulmonary congestion with intoxication and burn
injury leads to functional lung complications.
We observed that ethanol intoxication at the time of injury leads to a longer pause
between breaths (Penh), correlating with a decrease in the frequency of breaths per
minute. With this data, one would expect this slower breathing pattern, an indicator of
increased lung resistance, would result in deeper breaths, represented by an increase in
tidal volume. In contrast, we observed a decrease in tidal volume and minute volume, an
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indication that the mice are not able to compensate for the increase in lung resistance.
This breathing pattern may mirror agonal breathing, which is characterized by infrequent,
shallow breaths and has been observed in severely injured humans. This pattern is
precipitated by hypoxemia regardless of arterial carbon dioxide levels or pH, which may
be the case in our injured animals since agonal breathing in humans is typically viewed as
the terminal stage of respiration, occurring immediately before death [185]. When the
plethysmography measurements were taken at 24 hours in our experiments, majority of
the animals appeared either moribund or lethargic in the plethysmography chamber.
With 47% of death occurring between 24 and 72 hours, the breathing pattern we detected
in mice at 24 hours strongly suggests it can be characterized as agonal breathing,
indicating a mechanism behind the large percentage of mortality in the following 48
hours.
The location of the dorsal burn injury in this model could also restrict chest wall
movement during both the inflammatory and the wound healing phases, promoting the
observed decrease in breaths per minute, overall leading to decreased gas exchange.
Humans with chest, back or torso circumferential burns have breathing patterns with
rapid shallow breaths, not slow shallow breaths, as we have observed in our model [86].
These differences, however, may be attributed to the immediate care provided to human
burn patients. Torso circumferential burns can limit respiration and require a chest
escharotomy where incisions are made in the burn wound, releasing constricted and nonelastic damaged tissue, to restore chest movement. The mice in our model do not receive
circumferential burns, removing the need for escharotomy in the model, but the injury
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location may still lead to an altered breathing pattern. Tidal breathing is usually
interrupted every few minutes by a deep breath or yawn, which is needed to expand
underinflated alveoli. Restricted chest wall movement can cause burn patients to lose this
ability. Without this interruption in tidal volume, the alveoli eventually collapse in a
process known as atelectasis, resulting in decreased blood flow, oxygen exchange and the
ability of the lungs to expand [86, 186]. Our data demonstrate that the loss of lung
compliance with burn injury, even in the absence of inhalation injury, is further decreased
when intoxication precedes burn injury. The restricted chest movement and subsequent
collapse of alveoli may also explain the differences in breathing patterns in our mouse
model, in comparison to human burn patients. However, the 3-fold increase in Penh with
burn alone does not correspond to significantly increased mortality rates. This suggests
ethanol, not the location of the burn, leads to impaired lung function and elevated
mortality rates. Overall, these findings highlight pulmonary inflammation as an
underlying mechanism that contributes to the drastic mortality rate observed in mice
exposed to both ethanol and burn injury.
Apoptosis of type I and type II epithelial cells and neutrophil infiltration are
postulated as two main causes of ARDS [187]. Heighten infiltration or ineffective
removal of apoptotic neutrophils can prolong the inflammatory response, while damage
to epithelial cells and the capillary-alveolar interface can lead to increased lung
permeability. The resolution of pulmonary inflammation is influenced by the recognition
of apoptotic cells and efferocytosis by AMs [43, 170]. A defect in this process can
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substantially prolong the inflammatory response, leading to greater tissue damage. A
functioning population of AMs is therefore needed to regulate pulmonary inflammation.
The studies herein demonstrate intoxication and injury results in increased
numbers of apoptotic cells in lung tissue 24 h post-injury. AMs from intoxicated and
injured mice display functional components, MARCO and CD11b, both important in
efferocytosis. Morphological analysis of AMs also supports the capacity of a percentage
of AMs to effectively take up apoptotic cells, even after intoxication and injury.
Therefore, it does not seem intoxication at the time of injury completely inhibits the
function of AM efferocytosis. Whether ethanol reduces the percent of efferocytosis after
burn injury was not determined in this these studies. However, previous studies in our
laboratory found ethanol exposure decreased AM phagocytosis of P. aeruginosa and that
this was facilitated by a decrease in macrophage Fcγ- receptor after in vitro or in vivo
alcohol exposure [8, 76]. Efferocytosis is a separate and distinct process from the
phagocytosis of pathogens, therefore it is plausible alcohol can have differential effects
on both of these functions.
There are two main pathways in the initiation of apoptosis. First, pro-apoptotic
stimuli can signal the intrinsic pathway of mitochondrial BCL-2 and cytochrome c
release. Second, activation of death receptors, such as Fas and TNF-family receptors,
initiate the extrinsic pathway of apoptosis. Both of these pathways lead to caspase-3/7
activation and the subsequent cleavage of cellular protein and DNA fragmentation that
results in apoptosis [188]. Here we showed AMs isolated from intoxicated and burninjured mice spontaneously produced 5-fold more TNFα, a prominent death receptor
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activator. The literature suggests both apoptotic and necrotic cells are TUNEL [167],
but only apoptotic cells are caspase-3/7+. Our findings of active-caspase-3/7+ cells being
efferocytosed by AMs, supports an apoptosis pathway of cell death, and not necrosis, in
lung cells after intoxication and injury.
Clinical data revealed that burn injury alone leads to increased levels of
endotoxins in the bloodstream, peaking between 7 and 12 hours after injury [108].
Elevated levels of circulating endotoxin after burn injury has also been correlated to
increased incidences of multiple organ failure [109]. While the effect of ethanol and burn
injury on circulating endotoxin levels has not been determine, we postulate that increased
bacteria translocation from the gut would result in heightened levels of LPS, or other
bacterial products, into the blood stream. Previously, our laboratory demonstrated TLR4
signaling, but not TLR2, contributes to elevated pulmonary inflammation after
intoxication and injury [106]. LPS, a TLR4 ligand, has been shown to activate endothelial
cell production of pro-inflammatory mediators, including neutrophil chemokines [189].
Interestingly, our data indicate AMs and airways cells are not primary sources of KC.
Taken together, LPS-induced activation of capillary endothelial cells may facilitate
heightened levels of neutrophil chemokines we have observed in total lung tissue. In
addition to endotoxins, AM production of TNFα may also have an important role in
prolonged pulmonary inflammation. In human studies, TNFα activates endothelial cells
and induces the upregulation of adhesion molecules and IL-8 and IL-6 secretion,
resulting in transendothelial migration of neutrophils [190-192]. Furthermore, human
studies suggest apoptosis of AMs and epithelial cells in acute lung injury is induced by
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endotoxins and not hypoxemia [193, 194]. Our data revealed there was a trend toward
an increase in TLR4/MD-2 expression on AMs at 24 h. We speculate that if endotoxin
levels peak by 12 h after combined injury, that perhaps endotoxin-induced apoptosis
occurred long before our 24 h analysis, and is why we observe decreased number of AMs
in lung tissue.
Published studies from our laboratory indicate that long myosin light-chain kinase
(MLCK) activation mediates increased intestinal permeability after intoxication and burn
injury [97, 98]. Inhibition of MLCK activation, either through membrane permeant
inhibitor of MLCK (PIK) or studies using MLCK knockout (KO) mice, showed a
decrease in intestinal damage and bacterial translocation into the mesenteric lymph
nodes. Preliminary studies examined levels of apoptotic cells in the lungs of intoxicated
and burn-injured MLCK KO mice. We found that decreased tight junction disruption
after intoxication and bury injury resulted in a 75% decrease in apoptotic cells in the
lung, in comparison to wild type counterparts (p <0.05) (Figure 29). These data support
our hypothesis that systemic mediators, such as LPS or endotoxins, influence pulmonary
inflammation and apoptosis. Future studies are warranted to compare the role of AMs in
inflammation in MLCK KO mice to wild type mice.
The literature suggests that efferocytosis by AMs initiates the transition from an
inflammatory phase towards a resolution phase by stimulating the release of IL-10 and
TGFβ [43-46]. TGFβ has specifically been shown to inhibit TNFα-induced, IL-8
dependent migration of neutrophils through the endothelium [195]. We did not examine
levels of TGFβ, but this would be an interesting future direction for these studies. We
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Figure 29: Decreased number of apoptotic cells in the lung after intoxication and injury in
MLCK KO mice. An immunofluorescent in situ TUNEL assay was used to identify
apoptotic cells in lung tissue. Average number of apoptotic cells per 10x field after
intoxication and injury. *p < 0.05 versus sham vehicle WT, #p < 0.05 versus burn
ethanol WT by One Way ANOVA. Data are shown as mean ± SEM. N=3-4 animals per
group.

111
have analyzed lung IL-10, but have not seen changes in this cytokine 24 h after
intoxication and burn injury. We also did not detect a change in the IL-10R expression,
suggesting if exogenous IL-10 were administered, it may be able to activate an
inflammatory phenotype on AMs. Loss of AMs, in addition to minimal AM efferocytosis
of the abundant apoptotic cells, may result in deficient levels of anti-inflammatory
mediators that can initiate the resolution phase. Thus, this can prolong the proinflammatory phase. The heightened expression of scavenger receptor MARCO and
production of TNFα by AMs supports a pro-inflammatory phenotype. Excessive
inflammatory mediator production has been shown to inhibit apoptosis of neutrophils and
prolong their stay in tissue [196]. Our laboratory also demonstrated intoxication, prior to
burn injury and infection, decreased in neutrophil apoptosis and prolonged their stay in
the airways [143]. These factors support an extended pro-inflammatory phase that can
result in tissue damage and impair lung function. Collectively, these data also indicate
AMs 24 h post-injury may be activated by LPS. In response, they may upregulate
MARCO, express both ARG1 and iNOS, and secrete TNFα. Using recent macrophage
nomenclature guidelines these data suggest we can potentially classify AMs from
intoxicated and injury mice as M(LPS) [34] (Figure 30).
Clodronate experiments confirmed AMs also have a role in limiting neutrophil
numbers into the lungs after intoxication and injury. The negative correlation between
decreased AM numbers and increased neutrophil numbers proposes elevated neutrophil
accumulation after intoxication and injury is a result of AM deficiency in the lung tissue.
Our data show that both the loss of AMs and a heightened pro-inflammatory profile on
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Figure 30: AMs have a pro-inflammatory M(LPS) phenotype after intoxication and
injury. In steady-state conditions, AMs maintain tolerance and suppress inflammatory
responses through inhibitory receptors CD206 and SIRPα, that binds SP-A and SP-D. As
a result of heightened levels bacteria/LPS and IL-6 in the blood stream after intoxication
and injury, there is increased alveolar wall thickening, neutrophil accumulation into the
interstitium and an increase in neutrophil chemoattractants KC and MIP-2, and IL-6 in
lung tissue. The studies indicate AMs acquired an M(LPS) phenotype. We postulated
LPS activates through TLR4/MD-2. Co-illustration credit C.L. Shults
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remaining AMs, may prolong pulmonary inflammation after intoxication and injury,
underlining a mechanism for impaired lung function and increased incidences of
mortality.
Kinetic studies of AM life-span reveal AMs are long-lived cells with a half-life of
30 days and minimal self-renewal in steady-state lung conditions [12]. During lung
injury, loss of AMs results in the local proliferation of AMs and is the main mechanism
of repopulation [13-15]. In Appendix A (Figure 31&33-34), we identified a population
of intermediate AMs. Quantification of these cells after injury demonstrated a 1.5-fold
increase in this population (Figure 8C), indicating intermediate AMs may be actively
trying to repopulate loss of AMs in the alveolar space. The rate of repopulation after
injury and function of efferocytosis was not determined, but these activities would be an
interesting study to determine the effect of alcohol on the repopulation of AMs after
injury.
Our studies emphasize the imperative role of AMs in pulmonary inflammation
after intoxication and burn injury and the restoration of these multi-functional AMs could
be critical to re-establishing lung homeostasis and improving lung function. The
identification of local lung therapeutic agents that specifically target AMs may be
beneficial to attenuating pulmonary inflammation, overall reducing mortality in burn
patients. The data in this dissertation highlight MSCs a useful therapy to specifically
treat pulmonary inflammation. Intravenous administration of exogenous MSCs were
demonstrated to have the ability to reduce both lung and systemic IL-6, a cytokine that
has been described to play a causative role in the excessive pulmonary inflammation after
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intoxication and injury [107]. To this end, neutrophil chemokine KC levels and
neutrophil infiltration into the lungs were also reduced after MSC treatment. Whether this
was a direct outcome of decreased IL-6 levels was not determined in this study. However,
the literature implies that MSC production of anti-inflammatory mediators, such as IL-10
and TGFβ, can down regulate pro-inflammatory mediators, such as IL-6. In our study, we
did not observe increased levels of lung IL-10, but Lee et al. demonstrated the antiinflammatory factor, tumor necrosis factor-α induced protein 6,which is secreted by
MSCs trapped in the lungs can enter the bloodstream and reduce inflammation at the
primary site of injury [175]. In our intoxication and injury model, it is possible MSC
therapy attenuated pulmonary inflammation in more than one way. The secretion of antiinflammatory mediators by MSCs into circulation may localize to the burn injury,
dampening the release of IL-6, thereby decreasing systemic IL-6 levels and pulmonary
inflammation. Additionally, the entrapment of MSCs within the lung capillary bed allows
MSCs to activate alveolar macrophages to an anti-inflammatory phenotype, further
contributing to the reduction of lung inflammation. Alternatively, MSC attenuation of
pulmonary inflammation through alveolar macrophages may result in a decrease in
systemic IL-6, identifying the lungs one source that contributes to elevated serum levels
of this pro-inflammatory cytokine.
To our knowledge, clinical and experimental MSC therapy in burn injury has
focused on wound repair, through either the topical transplantation or injections of MSCs
near the site of injury [127-130]. Xue et al. demonstrated the plasticity of MSCs to
differentiate into tissue-specific cells and to promote accelerated wound healing, while
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others have shown an increase in neoangiogenesis and a decrease in cellular infiltration
at the wound site [130, 131]. Thus far, alternative routes of MSC administration and their
therapeutic applications is an understudied field in burn research [129]. We choose an
intravenous method of MSC administration in attempt to localize MSCs and their antiinflammatory properties to the lungs and believe that our study is the first to investigate
the effects of intravenous administered MSCs to target pulmonary inflammation after
intoxication and burn injury. We found a small percentage CFSE+ MSCs in the lungs 24
h after burn injury using flow cytometry, at a ratio of 100 CFSE+ MSCs per 350,000 total
cells (~0.3%) (Figure 23C). However, we could not identify CFSE+ cells in the lung
tissue. The small percentage of MSCs in the lungs at the time point could be due to a
various factors. While the majority of intravenous MSCs are localized to the lungs,
regardless of experimental model, bone fracture studies suggest viable MSCs are able to
home to the site of injury and promote fracture healing. These studies used
bioluminescent trafficking and confirmed a large percentage of MSCs get trapped in the
lungs 1 day after transfer, but a portion of MSCs home to the bone fracture site by 3 to 14
days after administration [197-199]. This delay in migration from the lungs to the site of
injury may support why we do not see MSCs near the burn wound at this 24 h time point.
Furthermore, intoxication at the time of bone fracture did not inhibit the migration of
MSCs given 24 h after injury [200]. Bioluminescence is a very sensitive technique that
shows the general location of labeled MSCs within a test subject, but the visualization of
individual fluorescently labeled cells may be more difficult to find within the several
million lung alveoli. Additionally, burn injury alone results in an increase in capillary

116
permeability and tissue edema, with a great need for fluid resuscitation [201], while
intoxicated and burn-injured patients require an even greater amount of fluid resuscitation
[89]. Our laboratory found that intoxication at the time of injury increases post-burn
dehydration, even after fluid resuscitation, while also causing a shift in fluid
compartments that results in greater ischemic end-organ damage [202]. The increase in
capillary permeability and loss of fluid from the vascular space may highly influence the
fate of infused MSCs. The large size of MSCs may not only trap them within the lung
capillary bed, but also retain them within constrained vasculature of intoxicated and burninjured mice. It is also possible the migration aptitude of the Gibco® MSCs differs from
freshly isolated primary bone marrow-derived MSCs. However, published studies have
confirmed the immunosuppressive ability of this cell line [203]. Overall, we can
conclude that even in the presence of acute dehydration and ischemia, MSCs are able to
exhibit an anti-inflammatory effect on the lungs, while also reducing systemic IL-6.
In conclusion, even though AMs may only be a small percentage of cells in the
lungs, their function and presence has a huge impact on normal lung function. These data
presented in this dissertation support our hypothesis that intoxication and burn injury
results in the loss of AMs through apoptosis, leading to elevated levels of neutrophil
infiltration and impaired lung function. Finally, AMs diverse functions and their
changeable activation state present an opportune therapeutic target to help control
pulmonary inflammation in all burn patients.
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APPENDIX A
CHARACTERIZATION OF LEUKOCYTE POPULATIONS IN THE LUNG
AFTER INTOXICATION AND INJURY
Results
Lung tissue was dissociated into a single cell suspension from both sham vehicle
and burn ethanol treatment groups and analyzed by flow cytometry [21]. Total live lung
cells were gated (Figure 31A) and examined for expression of CD11b and CD11c cell
surface markers (Figure 31B). Using these 2 markers we were able to subdivide lung
cells into 4 different populations, including AMs (Figure 31B, R1), intermediate
AMs/CD11b+ DCs (Figure 31B, R2), granulocytes (neutrophils) (Figure 31B, R3), and
lymphocytes/non-leukocytes (Figure 31B, R4), regardless of injury. While our main
focus was on the characterization of AMs, we confirmed the phenotype of all 4
populations and assessed whether intoxication and injury altered the frequency of these
individual subsets. First, forward scatter (FSC-cell size) and side scatter (SSCgranularity) plots were analyzed from each treatment group (Figure 31C&F). With
intoxication and injury, we visually noted the appearance of a population of cells within
total lung (Figure 31F, white dashed circle). Based on data presented in Chapter 3, as
well as previous data by our laboratory, we predicted this population of cells was
infiltrating neutrophils. To identify AMs, we first analyzed total live cells for
CD11c+CD11b- (Figure 31D&G) and noticed a decrease in the density of this population.
Further analysis of alveolar macrophages confirmed their expression of Siglec-F (Figure
31E&H). Within CD11c+CD11b- population we also can identify
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Figure 31. Flow cytometry analysis of leukocyte populations in lung tissue. Lung tissue
was obtained 24 hours post-injury and enzymatically dissociated into a single cell
suspension. Lung cells were stained for leukocyte cell markers. A) Total lung cells were
gated to include large myeloid cells (polygon gate) and exclude smaller lymphocytes and
dead cells. B) Summary of individual cell populations within the total lung gate using a
CD11c versus CD11c gating method. (R1) CD11c+CD11b- AMs (R2) CD11c+CD11b+
intermediate AMs and CD11b+ DCs (R3) CD11c-CD11b- lymphocytes/non-leukocytes
and (R4) CD11c-CD11b+ granulocytes (neutrophils). C-H) Representative gating of AMs
from both sham vehicle and burn ethanol groups. Flow profiles in sham vehicle were
selected for C) total lung cells (polygon gate), then D) CD11c+CD11b- cells (black gate),
then E) Siglec-F+ (CD11c+) cells (black gate), small black arrows indicate DCs within the
CD11c+CD11b- population. Flow profiles in burn ethanol were similarly selected for F)
total lung cells (polygon gate-white dash circle indicates infiltrating cells), then G)
CD11c+CD11b- cells (black gate), then H) Siglec-F+ (CD11c+) cells (black gate).
Changes in the density of cell populations indicate changes in the quantity of cells in a
population.
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CD11c+Siglec-F- DCs. Using a backgating tool we, we examined where
CD11c+CD11b+Siglec-F+ AMs were located within total lung cells in both treatment
groups (Figure 32A&D). AMs in sham vehicle varied in size (FSC) and granularity
(SSC), with the majority of AMs falling between 50-150K SSC (Figure 32A). However,
AMs from intoxicated and burn injured mice showed an increase in SSC, majority of
cells ranging from 100-225K (Figure 32D), suggesting combined injury activates AMs.
We further show CD11c+CD11b-Siglec-F+ cells are F4/80+ (Figure 32C&F).
Additionally, we examined Siglec-F+ cells and found a population of
CD11c+CD11b+Siglec-F+ cells adjacent on the plot to AMs (Figure 32B&E). Eosinophils
can be eliminated because they are Siglec-F+, but not CD11c+, therefore, we hypothesized
this additional population of Siglec-F+ cells were interstitial macrophages.
Analysis of CD11c+CD11b+ cells (Figure 33) revealed that the majority of the
cells from sham animals had a wide range of FSC and SSC (Figure 33A), while this
population from intoxication and injured mice had an increase in SSC (Figure 33C). We
next analyzed this population for F4/80 and Siglec-F expression in both treatment groups.
Using fluorescent minus one controls we established a F4/80-Siglec-F- and a
F4/80loSigle-F+population of cells (Figure 34A). F4/80-Siglec-F- also expressed MHC II
(Figure 34B), while F4/80loSiglec-F+ expressed similar levels of CD206 as AMs (Figure
34C). The literature suggests these CD11c+CD11b+ cells are an intermediate macrophage
population that replenish alveolar macrophages [204]. However, we believe we have
shown that CD11c+CD11b+ cells are representative of F4/80-Siglec-F-MHC II+ “CD11b+
DCs” and F4/80loSiglec-F+CD206+ intermediate AMs. We are hesitant to call
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Figure 32. Forward scatter and side scatter characteristics of AMs. Forward scatter (FSC)
is a measure of cell size and side scatter (SSC) is a measure of granularity. Data
representative of dissociated lung tissue from (A-C) sham vehicle and (D-F) burn ethanol
mice. A&D) CD11c+CD11b-Sigle-F+ AMs (red) were analyzed for FSC and SSC in total
lung cells. B&E) Location of Siglec-F+ cell populations within CD11c and CD11b gating
(red). There are two Siglec-F+ populations of cells, CD11b- and CD11b+. C&F)
Confirmation of F4/80 expression on CD11c+CD11b-Sigle-F+ AMs (red), in comparison
to a fluorescent minus one control (black).
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Figure 33. Forward scatter and side scatter characteristics of CD11b+CD11c+ cells. Data
representative of dissociated lung tissue from A&B) sham vehicle and C&D) burn
ethanol mice. A&C) CD11c+CD11b+cells (red) were analyzed for FSC and SSC in total
lung cells. B&D) Gating of CD11c+CD11b+ cells (red) that were analyzed for FSC versus
SSC in A&C.
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Figure 34. Characterization of CD11b+CD11c+ cells. CD11b+CD11c+ cells from
dissociated lung tissue were analyzed in sham vehicle and burn ethanol mice for Siglec-F
and F4/80 expression. A) Two populations were identified, Siglec-F+F4/80lo intermediate
AMs (magenta gate) and Siglec-F-F4/80- DCs (green gate). B) Expression levels of MHC
II on both intermediate AMs (magenta) and DCs (green). MHC II is expressed on SiglecF-F4/80- DCs, but not on Siglec-F+F4/80lo intermediate AMs. C) Expression levels of
CD206 on intermediate AMs (magenta) in comparison to CD11c+CD11b-Sigle-F+ AMs
(blue). CD206 levels on intermediate AMs are similar to AMs.
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intermediate AMs interstitial macrophages because 1) we did not assess their location in
the tissue and 2) it is thought that interstitial AMs do not express Siglec-F [21].
Additionally, clodronate depletion of AMs also eliminated intermediate AMs, but not
DCs, further confirming that these are two distinct populations (Figure 35). We originally
hypothesized the DC population were monocytes, but according to Misharin et al.,
monocytes in the lung are not MHC II+ [21].
The location of CD11c-CD11b+ cells was also assessed in total lung cells (Figure
36A&D), confirming that the infiltrating population observed with intoxication and
injury was CD11c-CD11b+Ly-6G+ neutrophils (Figure 31F & 36A-C) and we have
already established in Chapter 3 that there is a significant increase in CD11b+Ly-6G+
neutrophils after intoxication and injury. Eosinophils were not assessed, but they would
likely fall in the CD11c-CD11b+ population during an allergic stimuli. Lastly, CD11cCD11b- cells were characterized as F4/80-Ly-6G-Siglec-F- lymphocytes or nonleukocytes. Based on where they fall in the FSC and SSC plot, these cells likely are a mix
of lymphocytes, epithelial, endothelial cells or dead cells (Figure 36D&E).
In separate experiments, BAL cells were also obtained and their phenotype was
compared against AMs from dissociated lung tissue (Figure 37). BAL cells were
phenotyped as CD11c+CD11b+Siglec-F+F4/80+ (Figure 37D) and these cells represented
>92% of total BAL cells, highlighting BAL cells as a mainly pure population of AMs,
regardless of treatment. The small scattering of cells that would be CD11c+CD11b+
suggests BAL may also contain intermediate AMs. More studies on this are needed to
confirm these observations. We further analyzed the baseline expression of
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Figure 35. Clodronate liposome depletes CD11b+CD11c+Siglec-F+F4/80lo intermediate
AMs. Total lung cells from dissociated lung tissue were analyzed in sham vehicle and
burn ethanol mice after empty control and clodronate liposome treatment. Analysis of
intermediate AMs (magenta gate) and DCs (green gate) revealed clodronate liposome
selectively depleted only CD11b+CD11c+Siglec-F+F4/80lo intermediate AMs, confirming
their macrophage lineage.
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Figure 36. Forward scatter and side scatter characteristics of CD11b+CD11c- and CD11bCD11c- cells. Data representative of dissociated lung tissue from burn ethanol. A)
CD11b+CD11c- (red) were analyzed for FSC and SSC in total lung cells. White dashed
circle indicates infiltrating population after intoxication and injury. B) Gating of CD11cCD11b+ cells (red) that were analyzed for FSC versus SSC in A. C) Confirmation of Ly6G expression on CD11c-CD11b+ cells (red), in comparison to a fluorescent minus one
control. This confirmed a neutrophil phenotype. D) CD11b-CD11c- (red) were analyzed
for FSC and SSC in total lung cells. E) Gating of CD11c-CD11b- cells (red) that were
analyzed for FSC versus SSC in D. These small cells are lymphocytes, non-leukocytes, or
dead cells.
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Figure 37. Comparison of AMs from dissociated lung or BAL fluid in sham vehicle.
Lungs were either enzymatically dissociated into a single cell suspension or they were
lavaged 5x with 1 mL PBS and cells stained for AM markers. A-C) Representative gating
of AMs in BAL fluid. Flow profiles were selected for A) total lung cells (polygon gate),
then B) CD11c+CD11b- cells (black gate), then C) Siglec-F+(CD11c+) cells (black gate).
D) Histogram display of surface receptor fluorescent intensity on AMs from both
dissociated lung and BAL fluid, confirming the CD11c+CD11b-Sigle-F+ F4/80+ AM
phenotype (red) in comparison to fluorescent minus one (FMO) controls (black). A FMO
is where cells are stained for every antibody except one to determine fluorescence
crossover. This is done for each antibody.
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M1 markers, MARCO and MHC II, and M2 marker CD206 on both dissociated lung
AMs and BAL AMs from sham mice (Figure 38). There was no change in the expression
of MARCO or MHC II in sham animals and consistent with the literature, AMs
constitutively express CD206 [21, 169]. In summary, the nearly pure population AMs in
the BAL fluid can also be identified in dissociated lung tissue, emphasizing that both of
both BAL and dissociated lung tissue will be useful source for our AM-focused studies.
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Figure 38. Baseline expression of activation receptors on AMs from dissociated lung and
BAL-derived AMs in sham vehicle. Lungs were either enzymatically dissociated into a
single cell suspension or they were lavaged 5x with 1 mL PBS and cells stained for AM
markers. Histogram display of baseline surface receptor fluorescent intensity on sham
vehicle CD11c+CD11b-Sigle-F+ AMs (red) from both dissociated lung and BAL fluid in
comparison to fluorescent minus one (FMO) controls (black).
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APPENDIX B
DETAILED METHODS DESCRIPTION
Intoxication and Burn Injury Protocol
Materials
Hot plate
Water basins
Animal clippers with #40 surgical clip comb
Thermometer
1cc syringes with 27 gauge needle
3cc syringes with 20 gauge oral gavage needle
0.9% normal saline (sterile)
Burn injury template (check for proper size according to weight of mice)
Ketamine
Xylazine
Ethanol
Procedure
1. Fill two water basins with deionized water and heat one until 92-95°C, leaving the
other at room temperature.
2. Tail mark and weigh the mice.
3. Gavage mice with 400ul of ethanol mixed in water at the desired dose or water
alone. Allow 2-3 minutes between cages so there is time to shave and burn the
mice at their scheduled time.

4. Thirty (30) min. after ethanol administration, anesthetize the mice by injecting a
mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) in sterile saline by i.p.
injection.
5.

As soon as they are asleep (approx. 5 min. after anesthesia injection), thoroughly
shave the backs of the mice (Oster animal clippers with #40 comb).

6. One at a time, place animals in appropriate burning template to give a 14-16%
total body surface area scald injury according to their weight (see chart in
procedure room), and proceed with the burn injury (or sham – dunking mice in
room temp water). Make sure the shaved part of the back is “sealed” on the
burning template by gently pressing the mouse down into the template.
7. Hold the template containing the animal in the water for 7 seconds. Quickly blot
the mouse’s back on paper towels. Removing as much hot water as possible from
the animal prevents further scalding. Put the mouse back in a clean cage.
8.

As soon as possible after the injury, resuscitate each mouse with 1.0 ml of 0.9%
sterile saline (i.p.), pre-warmed in 37C water bath, or on warming pads.

9. Keep cages on heating pads for the next 3-4 hours.to help the mice recover from
procedure. Mice can be returned to the mouse room once they are walking and
fairly alert.
10. Place some food pellets on the bottom of each cage; the mice can’t stretch their
necks as easily to reach for food after burn injury. Replace water bottles.

Solutions:
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Ketamine/Xylazine: Diluted with 0.9% saline, 100 mg/kg ketamine, 10 mg/kg xylazine,
70.0 uL/mouse i.p. (see Ketamine/Xylazine protocol for how to make)
Ethanol:
1) 20% solution is the final concentration, made from the 95% stock ethanol
(marked for use in mice only). Dilute with water from the drinking fountain.
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Plethysmography
Materials
Mice
Barometric plethysmography apparatus
Mini screwdriver
1cc syringe with tubing
Timer
Procedure
2) Turn on computer and the 3 Buxco plethysmography machines.
3) Make sure all 4 chambers (1-4) are connected to machine.
4) Under Home, select calibration (wrench symbol) on the Loyola WBP file.
Calibrate all 4 chambers according to instructions. Close stop cock (turn to side)
at the top of each chamber during calibration. Re-open stop cock when chamber is
finished being calibrated. Use mini screw driver to adjust calibration setting and a
1cc syringe attached to tubing to inject air into the chamber. Make sure to reattach tubing to chamber after syringe is removed.
5) After calibration, select Basline and then Loyola WBP.
6) Enter in animal numbers and place mice into each chamber, making sure
chambers are completely closed, stop cock is facing up and all connections are
secure.
7) Under Session, select “Acknowledge All Sites”.
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8) Mice will have 5 min of acclimation, followed by 10 min of data recording. Set
timer for 15 min per mouse set.
9) After 15 min, remove mice and put next set of mice into chambers.
10) Under Session, select “Load New Subjects”. Enter in animal numbers for new set
of mice. Repeat steps 6-8 until all mice are done.
11) When finished recording data, under File select “End Session”. Make sure each
animal recording is selected and save data.
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Lung Tissue Dissociation
Materials
Collagenase D
DNase I
2% BSA/PBS
HBSS, no phenol red
gentleMACS C tubes
70 µm cell strainers
50mL conical tubes
gentleMACS Dissociator
Incubator
Centrifuge
Procedure
1. Modified from Miltenyi Biotec’s Lung Dissociation Kit protocol.
2. Prepare to digest lung lobe in 2mg/mL Collagenase D and 0.1mg/mL DNase I.
3. Prepare digestion buffer by dissolving the following into HBSS:
a. Collagense D: 100mg in 2ml in 15mL (100ul of this into 2.4mL is
2mg/mL).
b. DNase I: 10mg in 1ml (25ul of this into 2.4mL is 0.1mg/mL).
4. Remove lungs from mice and place upper left lobe into C tube with 2.4mL HBSS.
Add in 100ul prepared Collegenase D and 25ul DNase I.
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5. Close C tube tightly until you hear a snap and attach it upside down into slot on
the gentleMacs Dissociator.
6. Run gentleMACS program m_lung_01. Detach C tube from dissociator.
7. Incubate samples in incubator at 37°C for 20-25 min, manually mixing samples
every 5 min.
8. Remove tubes from incubator and use a pipet to gentle break up dissociated tissue
until it’s a single cell suspension (Do not use program m_lung_02. It is too harsh
on cells).
9. Perform brief 15 s centrifugation to collect sample at bottom of the tube.
10. Resuspend sample and filter through a 70 µm cell strainer into a 50mL conical
tube. Wash strainer with 2.5mL HBSS.
11. Discard strainer and centrifuge cells for 10 min at 300xg. Remove supernatant.
12. Resuspend in 2% BSA/PBS and count cells.
13. Cells are now ready for flow cytometry analysis.

[139]
Bronchoalveolar Lavage
Materials
Cold 1x PBS
60 Tubing
1cc syringe with 20g needle
25g needle
15mL conical tube
50mL conical tube
Procedure
1. Attach tubing to a 20g gauge needle with ¼ inch of tubing extended from needle.
2. Euthanize mouse and expose trachea and lungs. Using a 25g needle, gently pierce
the trachea below the first collangenous ring, Insert tubing (that is attached to
needle and syringe) into the trachea.
3. Lavage lungs 5 times with .8-.9 ml of cold PBS (keep PBS in 50mL conical tube
in ice bucket).
4. Pool all washes per animal into a 15mL conical tube
5. Spin cells 1200 rpm 3min 4° C.
6. Removed supernatant (~5mL) and store at at -80ºC for future cytokine analysis
studies.
7. Resuspend in 500ul RBC Lysis Buffer (ACK lysis buffer) and incubate 4 min on
ice.
8. Add 5ml PBS to quench reaction and spin cells 1200 rpm 3 min.
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9. Resuspend to 400ul in PBS and count cells.
10. Cells are ready for flow cytometry staining, chamber slide incubation or
cytocentrifugation onto slides.
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Flow Cytometry of Alveolar Macrophages
Materials
Antibodies
FACS Buffer: 1x PBS + 2% BSA
1x PBS
Eppindorf tubes
Plastic FACS tubes
Pipets
Centrifuge
Ice
Refrigerator or cold room
Waste container
Foil
Procedure
1. Obtain and count lung cells or BAL cells.
2. Add 1x106 lung cells or 1x105 BAL cells to eppindorf tubes.
3. Centrifuge at 1200rpm at 4oC for 5min.
4. Decant supernatant by gently “dumping” it into a waste container.
5. Block unspecific binding to the Fcy II/III receptor using anti-CD16/32 for 20 min
at 4oC on ice.
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6. Without washing cells, directly add in 50ul of primary antibodies diluted in FACS
buffer for 30 min at 4oC on ice in the dark. (Titer antibodies to determine
appropriate concentrations).
7. Wash 2x with FACS buffer.
8. Transfer cells to FACS tubes and immediately run unfixed cells resuspended in
400ul PBS on the BD Fortessa cytometer OR fix cells with 500ul 1% PFA for 15
min on ice. Wash with PBS and store in refrigerator at 4oC overnight covered in
foil and analyze samples the next day.
Controls:
9. Unstained Cells (from both sham vehicle and burn ethanol groups).
10. Fluorescence Minus One Control (FMO): Each fluorochrome needs 1 sample with
all fluorochromes, except for that 1 fluorochrome.
Antibodies to characterize alveolar macrophages:
CD11c APC-eFluor 780 (clone N418, eBioscience)
CD11b eFluor 450 (clone M1/70, eBioscience)
F4/80 APC (clone BM8, eBioscience)
Siglec-F PE-CF594 (clone E50-2440, BD Biosciences, San Jose, CA)
CD206 PE (clone C068C2, Biolegend, San Diego, CA)
Ly-6G (Gr-1) PE-Cy7 (clone RB6-8C5, eBioscience)
MHC II BD Horizon V500 (BD Biosciences)
TLR4/MD-2 APC (clone MTS510, eBioscience)
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MARCO FITC (Abd Serotec),
CD71 PerCP-eFluor 710 (clone R17217, eBiosciences)
IL-10R PE (clone 1B1.3a, BD Bioscience

[144]
Siglec-F Immunofluorescent Staining
1. Section OCT frozen lung tissue at 6µm onto slides.
2. Airdry slides for 1 hour at room temperature.
3. Fix slides 5 min in 4% PFA (15ml 16% PFA + 45ml cold PBS in a coplin jar) in
the hood.
4. Wash 3x with 1x cold PBS for 5 min. Pour PBS into coplin jar, then gently put
slides in PBS. Pouring PBS over slides in jar can cause delicate tissue to dislodge
from slide.
5. Block with superblock for 5 min (no longer or can ruin tissue).
6. ‘Dip” rinse slides (dip slides in PBS-don’t leave in PBS).
7. In a humidity chamber, incubate sections overnight at 4oC with rat anti-mouse
purified Siglec-F (Clone E50-2440, BD Biosciences) at 10ug/ml diluted in
antibody diluent (Immco).
8. Wash 3x with 1x cold PBS for 5 min each.
9. Incubate sections with secondary antibody goat anti-rat Alexa Fluor® 555 anti-rat
IgG (H+L) (Life Technologies)1:500 diluted in antibody diluent for 1 h at room
temperature.
10. Wash 3x with 1x cold PBS for 5 min each.
11. Air slides dry and mount with prolonged dapi gold (Life Technologies).

[145]
Active-Caspase 3 Staining
Materials
Humidity chamber
Coplin jars
1x PBS
Fixation : 4% Paraformaldehyde (PFA) in 1x PBS
Permeabilization: 0.1% Triton X-100 in 2% BSA/PBS
Blocking Reagent: 10% normal donkey serum + 0.1% Triton-100x
Antibody diluent: 2% BSA/PBS
Prolong Gold Dapi mounting medium
Procedure
1. Isolate BAL cells. Centrifuge 300g for 3 minutes. Lyse RBCs with ACK lysis
buffer for 4 mins on ice. Wash cells. Resuspend each pellet in 300ul media
and count by putting 10ul directly onto hemocytometer. After counting,
measure exactly how much media each sample was resuspended in.
2. BAL cells were cytocentrifuged (50,000 cells/200ul PBS or complete
medium) onto slides at 400RPM for 5 min.
3. Fix slides 5 min in 4% PFA (made in cold PBS) in coplin jars in the hood.
4. Wash 3x with 1x cold PBS for 5 min.
5. In humidity chamber, permiabilize with 0.1% Triton-100x in 2% BSA/PBS
for 30 min at room temperature.
6. Wash 3x with 1x cold PBS for 5 min.
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7. Block with 10% normal donkey serum (NDS) + 0.1% Triton-100x for 20
minutes at room temperature. Tap off serum.
8. Incubate slides overnight at 4oC with rabbit anti-active-caspase 3 (Abcam) at
10ug/ml diluted in 2% BSA/PBS.
9. Wash 3x with 1x cold PBS for 5 min each.
10. Incubate sections with secondary antibody donkey anti-rabbit 594 (Life
Technologies) diluted in 2%BSA/PBS for 45 min at room temperature.
11. Wash 3x with 1x cold PBS for 5 min each.
12. Air slides dry and mount with prolonged dapi gold (Life Technologies).
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ImageJ Analysis of Lung Tissue Histology
Materials
Lung H&E slides
Microscope with camera
ImageJ program
Procedure
1. Save 10 high power images per animal as jpeg files in a separate folder for each
animal.
2. Import folder as an “Image Sequence” in the ImageJ program.
3. Convert to 8-bit and adjust contrast and threshold if necessary. Must apply the same
settings to all sets of images.
4. Convert to binary.
5. Set measurements to be captured with threshold as area fraction.
6. Select “measure” and record.
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ImageJ Analysis of TUNEL+ Cells
Materials
Lung slides stained with TUNEL
Microscope with camera
ImageJ program
Procedure
7. Save 10 high power images per animal as jpeg files in a separate folder for each
animal.
8. Import folder as an “Image Sequence” in the ImageJ program.
9. Convert to 8-bit and adjust contrast and threshold if necessary. Must apply the same
settings to all sets of images.
10. Convert to binary.
11. Set measurements to be captured with threshold as area fraction.
12. Select analyze and “analyze particles” and set measurements to be captured:
a. Size 5-infinity
b. Circularity 0-100
13. Generate results and save data cell counts of TUNEL+ cells.

[149]
Clodronate Depletion of Alveolar Macrophages
Materials
Clodronate liposome
Control liposome
1cc syringe with 30g needle
50 Tubing
200ul pipet
Ketamine
Xylazine
Board and rubber band
Procedure
1. Bring clodronate and control liposomes (Encapsula NanoSciences, Brentwood,
TN) to room temperature. Gently mix vial contents (do not vortex).
2. Weigh and tail mark mice.
3. Anesthetized mice with100 mg/kg ketamine and 10 mg/kg xylazine.
4. Mice were suspended
5. Using a 200ul pipet, take 75ul of liposomes and pipet it into a 1cc syringe.
Attached needle with tubing to syringe and intratracheally administer liposomes.

[150]
Mesenchymal Stem Cells Tail Vein Injection
Materials
Wooden box with small hole in the side
27 gauge needle with syringe
Heating Pad
Ethanol (70% v/v)
PBS
MSCs (1x105/200ul pre-warmed PBS)
Procedure
1. Place animal cage on warming pad.
2. Bend needle to a 120° angle with the syringe.
3. Place mouse under Styrofoam housing, pulling tail through the side hole.
4. Wet the tail with ethanol and rub proximal portion of the tail until a lateral tail vein is
visible.
5. Insert needle into lateral vein and slowly inject MSCs or saline control.
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